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Regioselectively polysubstituted pyridines can be efficiently accessed from 2-halopyridines 
via a sequence involving C-H borylation, Suzuki-Miyaura cross-coupling and nucleophilic 
aromatic substitution chemistry. 
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Introduction 
The pyridine ring represents an essential structural component of many functional molecules 
including sensors, pharmaceuticals, agrochemicals, ligands for catalysis etc and is also found 
in numerous natural products (Fig. 1). 1,2,3,4   
                                                 
* Corresponding Author: Department of Chemistry, University of Durham, Science 





Figure 1. Representative functional pyridines 
As such, methods to synthesise functionalised pyridines are of great value and much effort has 
been applied towards this effect.5-11 Given the low reactivity of the electron deficient azinyl 
ring towards electrophilic aromatic substitution, most routes to substituted pyridines involve 
de novo synthesis with substituents and substitution patterns determined by the building blocks 
employed. However, the ability to manipulate a preformed pyridine ring is particularly valuable 
for late stage diversification. Among the various strategies for preparing polyfunctionalised 
pyridines in this way are ring metalation with various strong bases,12,13 radical substitution14,15 
and transition metal mediated C-H activation. 16,11 Whilst each has its merit, the last is 
particularly attractive providing both high atom and step efficiency and represent the ideal for 
green sustainable processes. Reflecting the versatility of the resulting arylboronate esters for 
further downstream transformations and the functional group tolerance of the process, Ir 
catalysed C-H borylation is a particularly attractive option for elaboration of a preformed 
pyridine ring.17,11 First reported by Miyaura and Ishiyama in 2002,18,19 the borylation of 
pyridine is challenged by the Lewis basicity of the azinyl nitrogen atom which can coordinate 
to and inhibit the catalytically active species. Moreover, the azinyl nitrogen also affects both 
the regiochemistry of pyridine borylation disfavouring substitution at the 2 and 6 positions and 
also rendering the products unstable with respect to protodeborylation.20-23   In recent work we 
have shown this effect can be modulated by the presence of an electron withdrawing 2-halo 
substituent which, not only sterically protects the catalyst by blocking co-ordination to the 
iridium centre but also lowers the basicity of the azinyl lone pair enhancing reactivity at the α-
positions and increasing stability to protodeborylation.24 The resultant 2-halopyridine boronate 
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esters are versatile building blocks for multi-directional elaboration and in this report we 
demonstrate this concept with the synthesis of a diverse set of trifunctional pyridine scaffolds. 
 
Results & Discussion 
Building on our earlier work, initial studies focused on the borylation of simple 2,4-
disubstituted pyridines. The borylation of 2-chloro-4-trifluoromethyl- and 2-chloro-4-
tertbutylpyridine 1 and 2 (Table 1), using [Ir(cod)OMe]2 (1.5 mol%), dtbpy (3 mol%) and 
B2Pin2 in THF, occurred as predicted at the sterically uninhibited 6-position. Although 
adjacent to the azinyl nitrogen atom, the stabilising effect of the 2-chloro substituent allowed 
the isolation of the boronate ester which could be identified by a characteristic downfield 
shift of the signal for the adjacent 5-hydrogen in the 1H NMR spectrum. Whilst sufficiently 
stable to be analysed as a crude product, attempts to chromatographically purify this 
compound were complicated by significant protodeborylation and it was more effective to 
use the crude reaction mixture directly in subsequent steps. Using the Suzuki-Miyuara 
reaction as a classic exemplar transformation, reaction with 4-iodo-nitrobenzene (1.5 equiv) 
in the presence of PdCl2(dppf) (5 mol%) as the precatalyst afforded the desired biaryl 5z in 
58% yield over the two steps (Table 1, entry 1). A range of arenes and heteroarenes (Fig. 2a), 
including those containing both electron withdrawing and donating substituents, proved 
viable giving moderate to good yields under these standard conditions. Having exploited the 
ability of the halogen to enable and direct the C-H borylation, it was then of interest to use 
this as a handle for further functionalisation. Using pyrrolidine as a test substrate, efficient 
reaction could be achieved by simply heating the halopyridine with an excess of the amine in 
THF in a sealed microwave vessel for 60 minutes.  This proved to be a general observation 
and was extended to include a range of amines (Fig. 2b), including primary, secondary cyclic 
and acyclic alkyl amines but not aniline. Attempts to carry out the whole sequence in a single 
operation were possible (Table 1 entry 6) but generally lead to more complex crude reaction 
mixtures and slightly lower overall yields. 
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Figure 2. Arenes and amines employed in this study 
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Table 1: Sequential borylation cross-coupling amination of 2-halopyridines             
 
Turning to the corresponding isonicotinates (Table 1, entries 13-21) initial attempts were 
hampered by inefficient borylation of the corresponding esters 2 and 3 under the “standard” 
conditions (~68% conversion compared with  >90% for the other substrates). Attributing this 
to competitive coordination of the Lewis acidic active catalyst, this could be simply 
addressed by increasing the catalyst loading to 5 mol% which enabled conversions in excess 
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of 90% to be routinely achieved. As with the earlier examples, cross-coupling of the resultant 
pyridyl boronate esters occurred efficiently. However initial attempts to employ methyl ester 
7z in the SNAr step led to the formation of the corresponding amide 13. Two strategies to 
circumvent this problem were developed. Simply replacing the methyl ester by a tert-butyl 
ester enabled the amino esters to be isolated in moderate yields (Table 1 entries 18-21) 
although aromatic amines were still not tolerated (Table 1, entry 20). Alternatively, using the 
more reactive 2-fluoropyridine starting material enhanced the facility of the SNAr reaction 
enabling lower reaction temperatures to be employed, leading to selective reaction at C-2 
even in the presence of the methyl ester (Table 1 entries 13-17).  
 
Figure 3: Structure of amide 13. 
Having demonstrated the possibility for multidirectional approaches around a pyridine 
template it was of interest to explore other starting pyridine substitution patterns. Retaining a 
2-halo substituent, as the borylation enabling (coordination blocking) but labile group, both 
2,3- and 2,5-nicotinates were then explored (Table 2). As expected borylation of the 2,5-
isomers 14 and 15 occurred preferentially at the sterically unencumbered C-5 site removed 
from the azinyl nitrogen.20-24 However small amounts (6-9%) of the α-azinyl (C-6) boronate 
ester could be observed in the crude reaction mixture but underwent rapid protodeborylation 
and was not isolable or detectable following the in situ cross coupling reaction. With the 2,3-
isomer 16, similar sterically directed borylation led exclusively to the 3-borylated product. 
For this group of compounds use of the smaller 2-fluoro starting material led to a faster 
reaction consistent with other observations describing fluorine to act as a C-H activation 
enhancing group.25,26,27 In both cases whilst the major boronate esters were isolable, it was 
more efficient to carry out a ‘one-pot’ process to afford the corresponding biaryl (17-19) in 
acceptable yields following application of the standard cross coupling conditions. As before 
SNAr chemistry with a variety of amines proved facile with anilines again requiring the use of 
the more reactive fluorine leaving group. With the 2,3 series use of a diamine enabled double 
substitution to afford the pyridodiazepinone 23 (Scheme 1a). For these substrates, reflecting 
the higher stability of a non α-azinyl boronate ester, the alternative order of events involving 
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initial displacement with the amine and then borylation of the corresponding 2-amino-
pyridine proved to be equally effective (Scheme 1b). 
 
Table 2: Sequential borylation cross-coupling amination of 2-halonicotinates             
 
Further extension of the levels of diversity possible can be realised through other standard 
functional group transformations (Scheme 1). For example, rather than exploit the 2-halo 
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substituent through SNAr chemistry other options exist using further metal catalysed 
transformations, with simple reduction using ammonium formate giving ester 25 (Scheme 1c) 
or via a second Suzuki-Miyaura reaction, the diarylpyridine 26 (Scheme 1d). Similarly, the 
ester substituents can easily be converted to the corresponding acid and hence provides a 
simple handle for the introduction of further variation into the reaction sequence (Scheme 
1e).  
 
Scheme 1: Exemplar diversity synthesis of pyridines enabled by C-H borylation 
 
Conclusion 
In this report we have demonstrated that the combination of iridium catalysed C-H borylation 
and SNAr chemistry provide a very simple method to elaborate a 2-halopyridine ring and 
provide substitution patterns that would be difficult to achieve using traditional heterocycle 
synthesis. The functional group tolerant nature of the borylation reaction allows many 
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alternative diverse elements to be incorporated in this sequence with minimal impact on the 
chemistry enabled. Given the wide scope for elaboration of the intermediate boronate ester 
the potential of the approach to generate diversity extends beyond the examples presented. 
Overall this study provides further testimony for the use of C-H borylation as a powerful 




General Procedure A: Tandem C-H Borylation-Suzuki-Miyaura Cross-Coupling 
Sequence: 
A solution of [Ir(COD)OMe]2 (5mol%), dtbpy (5mol%) and B2pin2 (1.2mol %)  in MTBE 
(0.4M) was prepared in a sealed vial and an aliquot then added to a thick-walled microwave 
synthesis vial containing the starting pyridine . The vessel was sealed with a crimp top 
septum cap and shaken until all of the substrate was dissolved. The reaction mixture was 
stirred on a magnetic stirring block or irradiated in a microwave reactor for the stated time 
and temperature. Upon completion, the volatiles were removed in vacuo to afford the crude 
borylated product. 
 
To the crude mixture under N2, was added palladium catalyst (5 mol%), base (2 eq.), aryl 
halide (1.1 – 2.0 eq.) and the stated solvent. The reaction was heated at the stated temperature 
for the stated time. The reaction mixture was diluted with water and extracted into EtOAc. 
The organic phase was dried over MgSO4, filtered and concentrated in vacuo to give the 
crude product. This was dry-loaded onto silica gel and purified by silica gel flash column 
chromatography using the stated solvent system. 
 
General Method B SNAr substitution of 2-fluorinated pyridines: 
A mixture of the 2-fluorinated pyridine derivatives (1 eq.), K2CO3 (2 eq.) and amine (2 eq.) 
were heated under reflux in dioxane for 6 h. The reaction was cooled to room temperature 
and filtered through Celite. Purification was achieved by flash column chromatography using 
EtOAc in hexane.  
 
General method C SNAr substitution of 2-chlorinated pyridines (-CO2Me substituted):  
To a sealed, evacuated and N2 backfilled vial containing the 2-chloropyridine derivative, 
methanol was added. To this solution, the amine was added and the reaction mixture was 
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irradiated in a microwave reactor at 130 oC for 30 mins. Following evaporation of volatiles, 
the resulting mixture was redissolved in DCM and washed with NaHCO3. Purification 
through column chromatography using EtOAc in hexane yielded the title compound.      
 
General Method D SNAr substitution of 2-chlorinated pyridines (non -CO2Me 
substituted): 
2-Chloropyridine derivatives were transferred to microwave vessel which was then sealed, 
evacuated and backfilled with N2. The amine (2ml) was then added and the reaction mixture 
was irradiated in a microwave reactor at 130 oC for 30 mins. Following the reaction, the 
resulting mixture was dissolved in DCM and washed with NaHCO3. Purification was 
achieved by flash column chromatography using EtOAc in Hexane. 
 
(5z) 4-Trifluoromethyl-6-chloro-2(4’-nitrophenyl)-pyridine  
Following general procedure A and purification using toluene in hexane (0-50%) yielded the 
title compound as a white solid (175 mg, 58 %). mp 120-121 ºC. δH (700 MHz, CDCl3) 8.36-
8.33 (2H, m, 3’,5’-H), 8.24-8.20 (2H, m, 2’,6’-H), 7.9 (1H, s, 3-H), 7.6 (1H, s, 5- H); δC (176 
MHz, CDCl3) 156.9 (C-2), 153.0 (C-6), 149.2 (C-4’), 142.3 (q, J = 34.7 Hz, C-4), 142.1 (C-
1’), 128.2 (C-2’,6’), 124.3 (C-3’,5’), 122.1 (q, J = 274 Hz, CF3), 120.3 (q, J = 3.6 Hz, C-5), 
115.4 (q, J = 3.4 Hz, C-3). υmax (ATR) 1601, 1564, 1516, 1409, 1350, 1328, 1263, 1173, 
1140, 1101, 1071, 860, 873, 818, 760, 707, 696, 675 cm-1. m/z (GC-MS, EI+) 304 ([M] 
(37Cl)]+, 31%), 302 ([M] (35Cl)]+, 100%). Accurate mass (ES+) m/z found [MH]+ 303.0138; 
C12H735ClF3N2O2 requires M, 303.0148. 
 
(9zA) 4-Trifluoromethyl-6-(N-pyrrolidin-yl)-2(4’-nitrophenyl)-pyridine 
Following general procedure D and purification using EtOAc in hexane (0-8%) yielded the 
title compound as a yellow solid (263 mg, 78 %). mp 212-213 oC. δH (700 MHz, CDCl3) 
8.31-8.27 (2H, m, 3’,5’-H), 8.22-8.18 (2H, m, 2’,6’-H), 7.19 (1H, s, 3-H), 6.57 (1H, s, 5-H), 
3.63-3.59 (4H, m, 2”,5”-H2), 2.11-2.04 (4H, m, 3”, 4”-H2); δC (176 MHz, CDCl3) 157.16 
(C6), 154.3 (C-2), 148.3 (C-4’), 145.1 (C-1’), 140.39 (q, J = 32.9, C-4), 127.7 (C-2’,6’), 
123.9 (C-3’,5’), 123.43 (q, J = 273 Hz, CF3), 103.6 (q, J = 3.3 Hz, C-3), 102.44 (q, J = 4.0 
Hz, C-5), 47.1 (C-2”,5”), 25.6 (C-3”,4”); υmax (ATR) 1616, 1601, 1564, 1519, 1492, 1480, 
1443, 1390, 1344, 1322, 1290, 1249, 1159, 1108, 1093, 1010, 972, 849, 826, 756, 722, 694, 
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671 cm-1. m/z (GC-MS, EI+) 337 ([M]+ 39%), 308 ([M-C2H5]+ 100%), Accurate Mass (ESI) 
m/z found [M+H]+ 338.1105; C16H15F3N3O2 requires M, 338.1116.  
 
(9zB) 4-Trifluoromethyl-6-(N-morpholin-yl)-2(4’-nitrophenyl)-pyridine 
Following general procedure D and purification using EtOAc in hexane (0-12%) yielded the 
title compound as a yellow solid (325 mg, 92 %). mp 268-269 oC. δH (700 MHz, CDCl3) 
8.35-8.26 (2H, m, 3’,5’-H), 8.23-8.12 (2H, m, 2’,6’-H), 7.33 (1H, s, 3-H), 6.85 (1H, s, 5-H), 
3.9-3.86 (4H, m, 3”,5”-H2), 3.71-3.67 (4H, m, 2”,6”-H2); δC (176 MHz, CDCl3) 159.4 (C-6), 
154.4 (C-2), 148.5 (C-4’), 144.6 (C-1’), 141.3 (q, J = 33.0 Hz, C-4), 127 (C-2’, 6’), 124.1 (C-
3’, 5’), 123.2 (q, J = 273 Hz, CF3), 106.1 (q, J = 3.3 Hz, C-3), 102.6 (q, J = 4.0 Hz, C-5), 66.7 
(C-3”,5”), 45.4 (C-2”,6”). υmax (ATR) 1603, 1567, 1517, 1438, 1324, 1302, 1242, 1161, 
1111, 982, 967, 847, 825, 757, 711, 695, 675 cm-1. m/z (GC-MS, EI+) (353 [M]+), 68%, (334 
[M-F]+, 17%), 308 ([MH-NO2]+, 24%). Accurate Mass (ESI) m/z found [M+H]+  354.1067; 
C16H15F3N3O3 requires M, 354.1066.  
 
(9zD) Diethyl-[6-(4’-nitrophenyl)-4-trifluoromethylpyridine-2-yl]amine  
Following general procedure D, and purification using EtOAc in hexane (0-8%) yielded 
the title compound as a yellow solid (207 mg, 61 %). mp 88-89 oC. δH (700 MHz, 
CDCl3) 8.32-8.27 (2H, m, 3’,5’-H),  8.21-8.15 (2H, m, 2’,6’-H), 7.20 (1H, s, 3-H), 6.7 
(1H, s, 5-H), 3.63-3.59 (4H, q, J = 7.1 Hz, 2”,4”-H2), 1.26 (6H, t, J = 7.1 Hz, 3”,5”-H3); 
δC (176 MHz, CDCl3) 157.5 (C-6), 154.3 (C-2), 148.3 (C-4’), 145.2 (C-1’), 140.7 (q, J = 
32.7, C-4), 127.6 (C-2’,6’), 124.0 (C-3’,5’), 123.4 (q, J = 273 Hz, CF3), 103.5 (q, J = 3.3 
Hz, C-3), 101.4 (q, J = 4.0 Hz, C-5), 43.13 (C-2”,4”), 12.9 (C-3”,5”). υmax (ATR) 1616, 
1601, 1566, 1516, 1503, 1442, 1349, 1344, 1332, 1263, 1249, 1175, 1123, 1110, 979, 
853, 829, 758, 710, 695, 676 cm-1. m/z (GC-MS, EI+) 339 ([M]+, 43%), 324 ([M-CH3]+, 
64%), 310 ([M-C2H5]+, 100%). Accurate Mass (ESI) m/z found [M+H]+ 340.1270; 
C16H17F3N3O2 requires M, 340.1273.  
(9zE) Butyl-[6-(4’-nitrophenyl)-4-trifluoromethylpyridine-2-yl]amine 
Following general procedure D, and purification using EtOAc in hexane (0-8%) yielded 
the title compound as a yellow solid (255 mg, 75 %), mp = 163-164 oC. δH (700 MHz, 
CDCl3) 8.31-8.26 (2H, m, 3’,5’-H), 8.18-8.11 (2H, m, 2’,6’-H), 7.2 (1H, d, J = 0.6 Hz, 
3-H), 6.6 (1H, s, 5-H), 4.9 (1H, s broad, NH), 3.44-3.39 (2H, m, 1”-H2), 1.69-1.64 (2H, 
m, 2”-H2), 1.51.44 (2H, m, 3”-H2), 1.0 (3H, t, J = 7.4 Hz, 4”-H3); δC (176 MHz, CDCl3) 
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159.1 (C-6), 154.7 (C-2’), 148.4 (C-4’), 144.7 (C-1’), 140.8 (q, J = 33.2 Hz, C-4), 127.7 
(C-2’,6’), 124.0 (C3’,5’), 123.2 (q, J = 273 Hz, CF3), 105.3 (q, J = 3.3 Hz, C-3), 102.8 
(C-5), 42.0 (C-2”), 31.6 (C-3”), 20.3 (C-4”), 14.0 (C-5”). υmax (ATR) 3401 (NH), 1625, 
1604, 1573, 1533, 1459, 1413, 1396, 1331, 1257, 1158, 1117, 1096, 860, 830, 757, 723, 
695, 678, 639 cm-1. m/z (GC-MS, EI+) 339 ([M]+, 31%), 310 ([M-C2H5]+, 52%), 296 
([M-C3H7]+, 100%). Accurate Mass (ESI) m/z found [M+H]+ 340.1276; C16H17F3N3O2 
requires M, 340.1273.  
(5y) 4-Trifluoromethyl-6-chloro-2-(4’-methoxyphenyl)-pyridine 
Following general procedure A, and purification using Et2O in hexane (0-5%) yielded 
the title compound as a yellow oil (105 mg, 36 %). δH (700 MHz, CDCl3) 7.99-7.94 
(2H, m, 2’,6’-H), 7.73 (1H, d, J = 0.6 Hz, 3-H), 7.37 (1H, d, J = 0.6 Hz, 5-H), 6.99-6.94 
(2H, m, 3’,5’-H), 3.85 (3H, s, OCH3); δC (176 MHz, CDCl3) 161.7 (C-4’), 159.1 (C-2), 
151.2 (C-6), 141.5 (q, J = 34.1 Hz, C-4), 129.0 (C-1’), 128.6 (C-2’,6’), 122.4 (q, J = 273 
Hz, CF3), 117.0 (q, J = 3.7 Hz, C-5), 114.4 (C-3’,5’), 113.4 (q, J = 3.7 Hz, C-3), 55.4 
(O-CH3). υmax (ATR) 1606, 1557, 1518, 1408, 1394, 1331, 1265, 1253, 1175, 1135, 
1098, 1072, 1031, 830, 694, 665, 581 cm-1. m/z (GC-MS, EI+) 289 [M (37Cl)]+, 33%, 
287 ([M (35Cl)]+, 100%). Accurate mass (ES+) m/z found [MH]+ 288.0401; 
C13H1035ClF3NO requires M, 288.0403. 
(9yA) 4-Trifluoromethyl-6-(N-pyrrolidin-yl)-2-(4’-methoxyphenyl)pyridine 
Following general procedure D, the crude mixture of 4-trifluoromethyl-6-chloro-2-
(4’methoxyphenyl)-pyridine in (~1.0 mmol) and pyrrolidine (0.46 ml, 5.5 mmol) were 
combined at 130 oC for 30 min. Purification through flash chromatography using EtOAc 
in hexane (0-5%) yielded the title compound as an off white solid (65 mg, 20 % (over 3 
steps)). mp 103-104 oC. δH (700 MHz, CDCl3) 8.06-8.00 (2H, m, 2’, 6’-H), 7.11 (1H, s, 
3H), 7.01-6.96 (2H, m, 3’,5’-H), 6.42 (1H, s, 5-H), 3.86 (3H, s, OCH3), 3.64-3.53 (4H, 
m, 2”,5”-H2), 2.08-2.00 (4H, m, 3”,4”-H2); δC (176 MHz, CDCl3) 160.7 (C-4’), 157.0 
(C-6), 156.6 (C-2), 140.0 ( q, J = 32.4 Hz, C-4), 132.0 (C-1’), 128.3 (C-2’,6’), 123.77 
(q, J = 273 Hz, CF3), 114.0 (C-3’,5’), 102.1 (q, J = 3.4 Hz, C-3), 100.0 (q, J = 4.0 Hz, 
C-5), 55.4 (O-CH3), 46.9 (C-2”,5”), 25.6 (C-3”,4”). υmax (ATR) 1613, 1563, 1497, 1460 
1439, 1408, 1389, 1351, 1333, 1304, 1293,1246, 1183, 1157, 1120, 1105, 1097, 1051, 
1032, 1014, 1004, 842, 825, 804, 782, 711, 680, 671, 648, 637, 618, 586, 522, 504 cm-1. 
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m/z (GC-MS, EI+) 323 [MH]+, 7%, 322 [M]+, 42%, 293 [MHOCH3]+, 100%; Accurate 
Mass (ESI) m/z found [M+H]+ 323.1364; C17H18F3N2O requires M, 323.1371.  
(5w) 2-Chloro-4-(trifluoromethyl)-6-(3’-methoxyphenyl)pyridine 
Following general procedure A, and purification using Et2O in heptane (0-3%) yielded 
the title compound as an off-white amorphous solid (147 mg, 51%). δH (700 MHz, 
CDCl3) 7.83 (1H, s, 5-H), 7.59 (1H, t, J = 2.3, 2’-H), 7.58 (1H, d, J = 7.9, 6’-H), 7.48 
(1H, s, 3-H), 7.41 (1H, t, J = 7.9, 5’-H), 7.03 (1H, dd, J = 7.9, 2.3, 4’-H), 3.91 (3H, s, 
OCH3); δC (176 MHz, CDCl3) 160.4 (C-3’), 159.4 (C-6), 152.4 (C-2), 141.8 (q, J = 
34.3, C-4), 138.0 (C-1’), 130.2 (C-5’), 122.3 (q, J = 274.0, CF3), 119.6 (C-6’), 118.7 (q, 
J = 3.7, C-3), 116.6 (C-4’), 114.8 (q, J = 3.5, C-5), 112.6 (C-2’), 55.6 (OCH3); δF (376 
MHz, CDCl3) −64.7 (s); νmax (ATR) 1600, 1561, 1459, 1400, 1333, 1274, 1221, 1177, 
1142, 1102 cm−1; Accurate Mass (ASAP) m/z found [M]+ 287.0330; C13H935ClF3NO 
requires M, 287.0325. 
(6z) 4-Tert butyl-6-chloro-2-(4’-nitrophenyl)pyridine 
Following general procedure A and purification using EtOAc in hexane (0-6%) yielded the 
title compound as an off white solid (117 mg, 40 %). mp 192-193 oC. δH (700 MHz, CDCl3) 
8.33-8.27 (2H, m, 3’,5’-H) 8.19-8.12 (2H, m, 2’,6’-H), 7.69 (1H, d, J = 1.5 Hz, 3-H), 7.34 
(1H, d, J = 1.5 Hz, 5-H), 1.38 (9H, s, 4-C(CH3)3); δC (176 MHz, CDCl3) 164.8 (C-4), 155.3 
(C-2), 152.3 (C-6), 148.5 (C-4’), 144.3 (C-1’), 128.0 (C-2’,6’), 124.1 (C-3’,5’), 121.4 (C-5), 
117.2 (C-3), 35.5 (4-C), 30.6 (CH3) υmax (ATR), 1588, 1533, 1509, 1410, 1338, 1171, 1104, 
856, 813, 762, 731, 698, 644 cm-1. Accurate mass (ES+) m/z found [MH]+ 291.0904; 
C15H1635ClN2O2 requires M, 291.0900.  
 
(10zA) 4-Tert butyl-6-(N-pyrrolidinyl)-2-(4’-nitrophenyl)pyridine 
Following general procedure D and purification using EtOAc in hexane (0-8%) yielded 
the title compound as a red solid (100 mg, 31 %), mp 180.5-182.5 oC. δH (700 MHz, 
CDCl3) 8.3-8.23 (2H, m, 3’,5’-H), 8.21-8.17 (2H, m, 2’,6’-H), 7.09 (1H, d, J = 1.3 Hz, 
3-H), 6.38 (1H, d, J = 1.3 Hz, 5-H), 3.55-3.60 (4H, m, 2”,5”-H2), 2.06-2.01 (4H, m, 
3”,4”-H2), 1.35 (9H, s, CH3); δC (176 MHz, CDCl3) 161.9 (C4),157.7 (C-6), 152.6 (C-
2), 147.7 (C-4’), 146.9 (C-4’), 127.6 (C-2’,6’), 123.8 (C-3’,5’), 107.03 (C-3), 103.4 (C-
5), 47.0 (C-2”,5”), 35.12 (4-C), 30.8 (4-C-(CH3)3)), 25.7 (C-3˶, 4˶). υmax (ATR) 1597, 
1549, 1501, 1476, 1456, 1323, 1107, 1101, 1011, 865, 850, 842, 832, 760, 698, 659, 
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631, 495 cm-1; m/z (GC-MS, EI+) 326 ([MH]+, 16%), 325 ([M]+, 78%). Accurate Mass 
(ESI) m/z found [M+H]+ 326.1869; C19H24N3O2 requires M, 326.1869.  
(6y) 4-Tert butyl-6-chloro-2-(4’-methoxyphenyl)pyridine 
Following general procedure A and purification using Et2O in hexane (0-5%) yielded the title 
compound as a colourless oil (121 mg, 44 %). δH (700 MHz, CDCl3) 7.96-7.92 (2H, m, 2’, 
6’-H), 7.55 (1H, d, J = 1.5 Hz, 3-H), 7.18 (1H, d, J = 1.5 Hz, 5-H), 7.00-6.95 (2H, m, 3’,5’-
H), 3.86 (3H, s, OCH3), 1.35 (9H, s, 4-C(CH3)3); δC (176 MHz, CDCl3) 164.0 (C-4), 160.9 
(C-4’), 157.7 (C-2), 151.6 (C-6), 131.0 (C-1’), 128.5 (C-2’, 6’), 119.0 (C-5), 115.5 (C3), 
114.2 (C-3’, 5’), 55.5 (OCH3), 36.3 (4-C), 30.6 (CH3). υmax (ATR) 1607, 1591, 1535, 1514, 
1462, 1410, 1385, 1303, 1247, 1175, 1111, 1074, 1031, 878, 831, 780, 650, 585, 507 cm-1. 
m/z (GC-MS, EI+) 277 ([M (37Cl)]+ , 31%), 275 ([M ( 35Cl)]+, 100%). Accurate mass (ES+) 
m/z found [MH]+ 276.1159; C16H1935ClNO requires M, 276.1155. 
 
(6v) 4-Tertbutyl-6-chloro-2-(3’-thiophenyl) pyridine 
Following general procedure A and purification using EtOAc in hexane (0-7%) yielded the 
title compound as a white solid (168 mg, 67%). mp 50-51 oC. δH (700 MHz, CDCl3) 8.95 
(1H, dd, J = 3.0, 1.3 Hz, 2’-H), 7.6 (1H, dd, J = 5.0, 1.3 Hz, 4’-H), 7.5 (1H, d, J = 1.5 Hz, 3- 
H), 7.3 (1H, dd, J = 5.0, 3.0 Hz, 5’-H), 7.18 (1H, d, J = 1.5 Hz, 5-H), 1.35 (9H, s, CH3); δC 
(176 MHz, CDCl3) 164.2 (C-4), 153.9 (C-2), 151.6 (C-6), 141.2 (C-3’), 126.5 (C-5’), 126.3 
(C-4’), 124.5 (C-2’), 119.4 (C-5), 116.1 (C-3), 35.3 (4-C), 30.6 (CH3). υmax (ATR) 1591, 
1540, 1477, 1434, 1422, 1362, 1346, 1287, 1200, 1165, 1079, 1062, 861, 831, 794, 774, 731, 




Following general procedure A and purification using EtOAc in hexane (0-10%) yielded the 
title compound as an off white solid (106 mg, 42%). mp. 96.5-97.5 oC. δH (700 MHz, CDCl3) 
8.12 (1H, d, J = 1.5 Hz, 3-H) 7.9 (1H, d, J = 3.1 Hz, 5’-H), 7.5 (1H, d, J = 3.1 Hz, 4’-H), 7.3 
(1H, d, J = 1.5 Hz, 5-H), 1.36 (9H, s, CH3); δC (176 MHz, CDCl3) 168.2 (C-2’), 165.0 (C-4), 
151.6 (C-2), 151.4 (C-6), 144.1 (C-5’), 122.2 (C-5), 122.0 (C-4’), 115.6 (C-3), 35.5 (4-C), 
30.6 (CH3). υmax (ATR) 1591, 1541, 1500, 1478, 1440, 1381, 1242, 1168, 1151, 1048, 874, 
863, 794, 770, 745, 723, 620, 583, 515 cm-1. m/z (GC-MS, EI+) 254 ([M (37Cl)]+, 24%), 252 
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([M (35Cl)]+, 65%). Accurate mass (ES+) m/z found [MH]+ 253.0584; C12H1535ClN2S requires 
M, 253.0566. 
 
(6t) 4-Tertbutyl-6-chloro-2,2’-bipyridinyl-4’-carboxylic acid methyl ester 
Following general procedure A and purification using EtOAc in chloroform (0-5%) yielded 
the title compound as a white solid (200 mg, 66 %). mp. 103-104 oC. δH (600 MHz, CDCl3) 
8.9 (1H, bs, 3’-H) 8.8 (1H, d, J = 5.0 Hz, 6’-H), 8.4 (1H, d, J = 1.6 Hz, 3-H), 7.86 (1H, dd, J 
= 5.0, 1.6 Hz, 5’-H), 7.3 (1H, d, J = 1.6 Hz, 5-H), 4.0 (3H, s, OCH3), 1.38 (9H, s, C(CH3)3); 
δC (151 MHz, CDCl3) 165.8 (C=O), 164.7 (C-4), 156.3 (C-2’), 155.7 (C-2), 151.5 (C-6), 
150.0 (C-6’), 138.7 (C-4’), 123.3 (C-5’), 122.0 (C-5), 121.0 (C-3’), 117.2 (C-3), 52.8 
(OCH3), 35.5 (4-C), 30.6 (CCH3). υmax (ATR), 1726 (C=O), 1585, 1532, 1478, 1438, 1373, 
1365, 1356, 1315, 1294, 1268, 1165, 1133, 1100, 966, 891, 859, 769, 751, 694, 674, 650 cm-
1. m/z (GC-MS, EI+) 306 ([M(37Cl)]+, 8%), 304 ([M (35Cl)]+, 25%), 291 ([M (37Cl)-CH3]+, 
37%), 289 ([M (35Cl)-CH3]+, 100%). Accurate mass (ES+) m/z found [MH]+ 305.1065; 
C16H1735ClN2O2 requires M, 305.1057. 
 
(7z) Methyl-6-chloro-2-(4’-nitrophenyl)pyridine-4-carboxylate 
Following general procedure A and purification using DCM in toluene (0-30%) yielded the 
title compound as a yellow solid (130 mg, 45 %), mp 166-167 oC. δH (700 MHz, CDCl3) 
8.36-8.33 (2H, m, 3’,5’-H), 8.3 (1H, d, J = 1.1 Hz, 3-H), 8.3-8.23 (2H, m, 2’,6’-H), 7.9 (1H, 
d, J = 1.1 Hz, 5-H), 4.0 (3H, s, OCH3). δC (176 MHz, CDCl3) 164.3 (C=O), 156.9 (C-2), 
152.9 (C-6), 149.0 (C-4’), 142.8 (C1’), 141.5 (C-4), 128.1 (C-2’,6’), 124.3 (C-3’,5’), 123.8 
(C-3), 119.0 (C-5), 53.4 (OCH3). υmax (ATR) 1733 (C=O), 1591, 1557, 1514, 1439, 1404, 
1340, 1317, 1252, 1244, 1156, 1104, 982, 857, 818, 770, 755, 742, 722, 689 cm-1; m/z (GC-
MS, EI+) 294 ([M (37Cl)]+, 33%), 292 ([M (35Cl)]+, 100%). Accurate mass (ES+) m/z found 
[MH]+ 293.0344; C13H1035ClN2O4 requires M, 293.0329.  
 
(7y) Methyl-6-chloro-2-(4’-methoxyphenyl)-pyridine-4-carboxylate 
Following general procedure A and purification using EtOAc in hexane (0-10%) yielded the 
title compound as a white solid (134.5 mg, 48 %). mp. 102-103 oC. δH (700 MHz, CDCl3) 
8.11 (1H, d, J = 1.2 Hz, 3- H), 8.03-7.96 (2H, m, 2’,6’-H), 7.7 (1H, d, J = 1.2 Hz, 5-H), 7.01-
6.93 (2H, m, 3’,5’-H), 4.0 (3H, s, CO2CH3), 3.86 (3H, s, 4’-OCH3); δC (176 MHz, CDCl3) 
164.8 (C=O), 161.4 (C-4’), 158.7 (C-2), 152.0 (C-6), 140.8 (C-4), 129.6 (C-1’), 128.6 (C-
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2’,6’), 121.1 (C-5), 117.3 (C3), 114.4 (C-3’,5’), 55.5 (4’-OCH3), 53.1 (CO2CH3) υmax (ATR) 
1734 (C=O), 1606, 1597, 1583, 1549, 1519, 1441, 1404, 1390, 1302, 1256, 1180, 1161, 
1113, 1071, 1021, 981, 824, 761, 732, 615, 585 cm-1. m/z (GC-MS, EI+) 279 ([M (37Cl)]+, 
32%), 277 ([M (35Cl)]+, 100%). Accurate mass (ES+) m/z found [MH]+ 278.0600; 
C14H1335ClNO3 requires M, 278.0584. 
 
(7’y) methyl 2-fluoro-6-(4’-methoxyphenyl)pyridine-4-carboxylate 
Following general procedure A and purification using EtOAc in hexanes (0-20%) yielded the 
title compound as a colourless oil (157 mg, 55%). δH (700 MHz, CDCl3) 8.13 (1H, m, 5-H), 
8.03 (2H, m, 2’, 6’-H), 7.32 (1H, m, 3-H), 7.00 (2H, m, 3’, 5’-H), 4.00 (3H, s, CO2CH3), 3.88 
(3H, s, COCH3); δC (176 MHz, CDCl3) 164.8 (d, J = 4.2, CO2CH3), 162.3 (d, J = 247.0, C-2), 
161.5 (C-4’), 157.2 (d, J = 14.0, C-6), 143.4 (d, J = 8.0, C-4), 129.5 (C-1’), 128.6 (C-2’, 6’), 
116.3 (d, J = 5.0, C-5), 114.4 (C-3’, 5’), 106.7 (d, J = 40.0 Hz, C-3), 55.6 (CO2CH3), 53.1 
(OCH3); δF (376 MHz, CDCl3) -66.2 (s); νmax (ATR) 1733, 1608, 1568, 1520, 1420, 1396, 
1352, 1252, 1206 1177 cm−1; GC/MS (EI) m/z 261 [M]+, 246 [M−CH3]+, 230 [M−OCH3]. 
Accurate Mass (ASAP) m/z found [M]+ 261.0811; C14H12FNO3 requires M, 261.0801. 
 
(11yA) Methyl 2-(4’-methoxyphenyl)-6-(pyrrolidin-1”-yl)pyridine-4-carboxylate 
Following general procedure B and purification using EtOAc in hexane (0-15%) yielded the 
title compound as a white amorphous solid (32 mg 85%) δH (600 MHz, CDCl3) 8.02 (2H, d, J 
= 8.8 Hz, 2’, 6’-H), 7.46 (1H, d, J = 1.2 Hz, 3-H), 6.95 (2H, d, J = 8.8 Hz, 3’, 5’-H), 6.83 
(1H. d, J = 1.2 Hz, 5-H), 3.93 (3H, s, CO2CH3), 3.84 (3H, s, 4’-OCH3), 3.54-3.62 (4H, m, 
2’’,5’’-H2), 2.11 – 1.92 (4H, m, 3’’H, 4’’-H2). δC (151 MHz, CDCl3) 166.86 (C=O), 161.08 
(C-4’), 157.22 (C-2), 156.11 (C-2), 155.8 (C-6), 132.1 (C-1’), 139.08 (C-4), 128.1 (C-2’, 6’), 
113.8 (C-3’, 5’), 105.8 (C-3), 104.2 (C-5), 55.31 (4’-OCH3), 52.36 (CO2CH3), 46.9 (C-2’’, 
5’’), 25.5 (C-3’’, 4’’). νmax (ATR) 2949, 2848, 1719, 1611, 1554, 1444, 1243, 1030, 1178, 
766 cm-1. GC/MS (EI) m/z 313.1 [M+H]+ (100%). Accurate Mass (ES+) m/z found [M+H]+ 
313.1562, C18H21N2O3 requires M, 313.1552. 
 
(7’x) Methyl 2-fluoro-6-(4’-trifluoromethylphenyl) pyridine-4-carboxylate 
Following general procedure A and purification using C18 reverse phase chromatography 
(H2O: MeCN, 0-100%) to yield the title compound as a white amorphous solid (151 mg, 
50%). δH (700 MHz, CDCl3) 8.22 (1H, dd, J = 2.0, 0.8 Hz, 5-H), 8.15 (2H, d, J = 8.4, 2’,6’-
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H), 7.74 (2H, d, J = 8.4, 3’,5’-H), 7.46 (1H. dd, 0.8, 0.4 Hz, 3-H), 4.01 (3H, s, -OCH3). δC 
(176 MHz, CDCl3) 164.3 (d, J = 4.1 Hz C=O), 163.8 (d, J = 241.1 Hz, C-2), 155.5 (d, J = 
14.0 Hz, C-6) 143.7 (d, J = 6.9 Hz, C-4), 139.92 (C-1’), 131.8 (q, J = 32.2 Hz, C-6’), 127.3 
(C-2’, 6’), 125.8 (C-3’, 5’), 124.0 (q, J = 263.3 Hz, -CF3), 117.3 (d, J = 4.7 Hz C-5), 108.8 (d, 
J = 39.7 Hz, C-3)  53.1 (-OCH3).  δF (376 MHz, CDCl3) -62.78 (-CF3), -65.15 (Ar-F). νmax 
(ATR) 2957, 2256, 1741, 1578, 1329, 1255, 1136, 905, 731 cm-1. GC/MS (EI) m/z  found 
[M+H]+ 300.0, [M+MeCN+H]+ 341.1. Accurate Mass (ES+) m/z found [M+H]+ 300.0670, 
C14H10F4NO2 requires M 300.0648.  
 
(11xB) Methyl 2-(morpholin-4”-yl)-6-[4’-(trifluoromethyl)phenyl]pyridine-4-carboxylate 
Following general procedure B and purification using EtOAc in hexane (0-15%) yielded the 
title compound as an off white solid (28 mg, 83%). mp. 272-273 oC (ethanol). δH (599 MHz, 
CDCl3) 8.14 (2H, d, J = 8.3 Hz, 3’, 5’-H), 7.70 (2H, d, J = 8.3 Hz, 2’, 6’-H), 7.69 (1H, d, J = 
1.0 Hz, 3-H), 7.25 (1H, d, J = 1.0 Hz, 5-H), 3.97 (3H, s, -OCH3), 3.90 – 3.83 (2H, m, 3’’, 5’’-
H2), 3.71 – 3.64 (1H, m, 2’’, 6’’-H2). δC (151 MHz, CDCl3) 166.1 (C=O), 159.54 (C-2), 
154.6 (C-4), 142.3 (C-6), 140.0 (C-1’), 130.9 (q, J = 30.7 Hz, C-4’) 127.1 (C-2’’, 6’’), 125.5 
(q, J = 4.0 Hz C-3’’, 5’’), 124.2 (q, J = 271.0 Hz -CF3), 109.42 (C-3), 106.1 (C-5), 66.7 (C-
3’’, 5’’), 52.6 (-OCH3), 45.5 (C-2’’, 6’’). δF (376 MHz, CDCl3) -62.56. νmax (ATR) 2960, 
2860, 2259, 1734, 1604, 1563, 1444, 1237, 1124 cm-1. GC/MS (EI) m/z  found [M+H]+ 367.1. 
Accurate Mass (ES+) m/z found [M+H]+ 367.1279, C18H18F3N2O3 requires M 367.1270.  
 
(11xE) methyl 2-(butylamino)-6-[4’-(trifluoromethyl)phenyl]pyridine-4-carboxylate  
Following general procedure B and purification using EtOAc in hexane (0-40%) yielded the 
title compound as a light yellow oil (36 mg, 64%). δH (700 MHz, CDCl3) 8.10 (1H, d, J = 7.6 
Hz, 2’, 6’-H), 7.71 (2H, d, J = 7.6 Hz, 3’, 5’H), 7.55 (1H, d, J = 1.1 Hz, 3-H), 6.98 (1H, d, J 
= 1.1 Hz, 5-H), 3.95 (3H, s, -OCH3), 3.39 (2H, q, J = 6.7 Hz, 1’’-H2), 1.70 – 1.62 (2H, m, 
2’’-H2), 1.46 (1H, m, 3’’-H2), 0.97 (3H, t, J = 7.4 Hz, 4’’-CH3). δC (176 MHz, CDCl3) 166.1 
(C=O), 166.0 (C-2), 158.98 (C-6), 154.3 (C-4) 140.0 (C-1’), 130.8 (q, J = 30.8 Hz, C-4’) 
127.1 (C-2’, 6’) , 125.5 (q, J = 3.8 Hz, C-3’, 5’), 124.1 (q, J = 272.0 Hz -CF3), 108.6 (C-3), 
106.1 (C-5), 52.6 (-OCH3), 42.0 (C-1’’), 31.5 (C-2’’), 20.2 (C-3’’), 13.8 (C-4’’). δF (376 
MHz, CDCl3) -62.58 (-CF3). νmax (ATR) 3423, 2960, 2259, 1724, 1571, 1329, 1249, 1124 cm-
1. GC/MS (EI) m/z  found [M+H]+ 353.5. Accurate Mass (ES+) m/z found [M+H]+ 353.1484, 
C18H20F3N2O2 requires M 353.1477.  
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(8z) Tert butyl 2-chloro-6-(4’-nitrophenyl)pyridine-4-carboxylate 
Following general procedure A and purification using CHCl3 in hexane (0-60%) yielded the 
title compound as a bright yellow solid (203 mg, 61%). mp 141-142 oC (methanol). δH (599 
MHz, CDCl3) 8.32 (2H, d, J = 8.9 Hz, 3’,5’-H), 8.23 – 8.19 (3H, m, 2’,6’, 5-H), 7.81 (1H, d, 
J = 1.1 Hz, 3-H), 1.62 (9H, s, OC(CH3)3). δC (151 MHz, CDCl3) 162.5 (C=O), 156.0 (C-6), 
152.5 (C-2), 148.7 (C-4’), 143.32 (C-4), 142.8 (C-1’), 127.9 (C-2’, 6’), 124.1 (C-3’, 5’), 
123.6 (C-3), 118.9 (C-5), 83.7 (OC(CH3)3), 28.0 ((CH3)3). νmax (ATR) 2984, 1719, 1593, 
1548, 1524, 1346, 1160, 861 cm-1.  GC/MS (EI) m/z  found 325.3 ([M (35Cl)+H]+ 100%), 
327.3 ([M (37Cl)+H]+ 31%). Accurate Mass (ES+) m/z found [M (35Cl)+H]+ 335.0803 , [M-
tBu+H]+ 279.0191, C16H1635ClN2O4 requires M 335.0799. 
 
(12zB) Tert butyl 2-(morpholin-4”-yl)-6-(4’-nitrophenyl)pyridine-4-carboxylate 
Following general procedure D and purification using EtOAc in hexane (0-15%) yielded the 
title compound as a bright yellow solid (27 mg, 78%). mp 216-217 oC (ethanol). δH (600 
MHz, CDCl3) 8.30 (2H, d, J = 8.9 Hz, 3’, 5’-H), 8.19 (2H, d, J = 8.9 Hz, 2’, 6’-H), 7.66 (1H, 
d, J = 1.0 Hz, 3-H),  7.24 (1H, d, J = 1.0 Hz, 5-H), 3.88 (4H, t, J = 4.9 Hz, 3’’, 5’’-H2), 3.69 
(4H, t, J = 4.9 Hz, 2’’, 6’’-H2), 1.63 (9H, s, -(CH3)3). δC (151 MHz, CDCl3) 164.4 (C=O) , 
159.5 (C-2), 153.3 (C-4’), 148.1 (C-1’), 145.0 (C-6), 142.1 (C-4), 127.6 (C-2’, 6’), 123.8 (C-
3’, 5’), 110.0 (C-3), 106.8 (C-5), 82.6 (-C(CH3)3), 66.6 (C-3’’, 5’’), 45.6 (C-2’’, 6’’), 28.1 (-
(CH3)3). νmax (ATR) 2982, 2863, 1717, 1596, 1563, 1516, 1433, 1341, 1251, 998 cm-1. 
GC/MS (EI) m/z  found 386.1 ([M+H]+ 100%), 330.1 ([M-tBu+H]+ 62%). Accurate Mass 
(ES+) m/z found [M+H]+ 386.1726, C20H24N3O5 requires M 386.1716. 
 
(8y) Tert butyl 2-chloro-6-(4’-methoxyphenyl)pyridine-4-carboxylate 
Following general procedure A and purification using CHCl3 in hexane (0-55%) yielded the 
title compound as an off white solid (182 mg, 57%). mp, 119-120 oC (methanol). δH (600 
MHz, CDCl3) 8.07 (1H, d, J = 1.2 Hz, 3-H), 8.01 – 7.96 (2H, m, 2’, 6’-H), 7.63 (1H, d, J = 
1.1 Hz, 5-H), 7.01 – 6.95 (2H, m, 3’,5’-H), 3.85 (3H, s, -OCH3), 1.61 (9H, s, -(CH3)3). δC 
(151 MHz, CDCl3)163.2 (C=O), 161.2 (C-4’), 158.4 (C-6), 151.8 (C-2), 142.7 (C-4), 129.7 
(C-1’), 128.5 (C-5), 121.0 (C-2’, 6’), 117.3 (C-3), 114.22 (C-3’ 5’), 83.01 (-C(CH3)3, 55.37 (-
OCH3), 28.0 (OC(CH3)3). νmax (ATR) 2986, 2874, 1728, 1595, 1548, 1415, 1323, 1238, 1147, 
1027 cm-1. GC/MS (EI) m/z  found 320.6 ([M(35Cl)+H]+ 72%), 322.5 ([M(37Cl)+H]+ 21%). 
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Accurate Mass (ES+) m/z found [M(35Cl)+H]+ 320.1071, C17H19NO335Cl requires M 
320.1053. 
 
(12yA) Tert butyl 2-(4’-methoxyphenyl)-6-(pyrrolidin”-yl)pyridine-4-carboxylate 
 
Following general procedure D and purification using EtOAC in hexane (0-20%) yielded the 
title compound as an off white amorphous solid (41 mg, 90%). δH (600 MHz, CDCl3) 8.01 
(2H, d, J = 8.7 Hz, 2’, 6’-H), 7.40 (1H, d, J = 1.1 Hz, 3-H), 6.98 (2H, d, J = 8.7 Hz, 3’, 5’-H), 
6.82 (1H, d, J = 1.1 Hz, 5-H), 3.86 (3H, s, -OCH3), 3.57-3.63 (4H, m, 3’’, 4’’-H2), 2.13 – 
1.93 (4H, m, 2’’,5’’-H2), 1.61 (9H, s, -(CH3)3). δC (151 MHz, CDC3) 165.4 (C=O), 160.3 (C-
4’), 155.5 (C-2) 141.0 (C-6), 128.2 (C-2’,6’), 124.6 (C-1’), 121.6 (C-4), 113.8 (C-3’,5’), 
106.0 (C-3), 104.2 (C-5), 81.7 (-C(CH3)3), 55.3 (-OCH3), 47.0 (C-2’’,5’’), 28.1 (C(CH3)3), 
25.5 (C-3’’,4’’). νmax (ATR) 2972, 2859, 1714, 1607, 1557, 1459, 1382, 1246, 1030 cm-1. 
GC/MS (EI) m/z found 356.3 ([M+H]+ 100%), Accurate Mass (ES+) m/z found ([M+H]+ 
355.2022, C21H27N2O3 requires M 355.2022. 
 
(8x) tert-butyl 2-chloro-6-(4-trifluromethy-lphenyl)pyridine-4-carboxylate 
Following general procedure A and purification using C18 reverse phase chromatography 
(H2O: MeCN, 0-100%) yielded the title compound as a light brown amorphous solid (140 
mg, 39%). δH (700 MHz, CDCl3) 8.19 (1H, d, J = 1.1 Hz, 3-H), 8.18 – 8.15 (2H, d, J = 1, 2’, 
6’-H), 7.79 (1H, d, J = 1.1 Hz, 5-H), 7.74 (2H, d, J = 8.1 Hz m, 3’, 5’-H), 1.63 (9H, s, -
(CH3)3).  δC (176 MHz, CDCl3) 162.7 (C=O), 157.0 (C-2), 152.3 (C-1’), 143.1 (C-4), 140.4 
(C-6), 127.4 (C-2’, 6’), 125.8 (q, J = 3.9 Hz, C-3’, 5’), 123.9 (q, J = 272.2 Hz, -CF3), 123.0 
(C-5), 118.5 (C-3), 83.4 (-C(CH3)3), 28.0 (-(CH3)3). δF (376 MHz, CDCl3) -62.72 (-CF3). 
νmax (ATR) 2975, 2887, 1726, 1557, 1471, 1382, 1326, 1261, 1131, 950 cm-1. GC/MS (EI) 
m/z found 358.1 ([M(35Cl)+H]+ 100%), 360.1 ([M(37Cl)+H]+ 39%). Accurate Mass (ES+) m/z 
found [M(35Cl)+H]+ 358.0826, [M(35Cl)-tBu+H]+ 302.0210, C17H1635ClF3NO2 requires M 
358.0822. 
 
(12xA) tert-butyl 2-(pyrrolidin-1-yl)-6-[4-(trifluoromethyl)phenyl]pyridine-4-carboxylate 
Following general procedure D and purification using EtOAC in hexane (0-10%) yielded the 
title compound as a white solid (39 mg, 90%). mp 168-169 oC (ethanol). δH (600 MHz, 
CDCl3) 8.19 – 8.15 (2H, d, J = 8.2 Hz, 2’, 6’-H), 7.69 (2H, d, J = 8.2 Hz, 3’, 5’-H), 7.48 (1H, 
d, J = 1.1 Hz, 3-H), 6.92 (1H, d, J = 1.1 Hz, 5-H), 3.62-3.58 (4H, m, 2’’, 5’’-H), 2.02-2.07 
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(4H, m, 3’, 4’H), 1.62 (9H, s, -(CH3)3). δC (151 MHz, CDCl3) 165.1 (C=O), 157.36 (C-2), 
154.32 (C-6), 142.81 (C-4), 141.2 (C-1’), 130.4 (q, J = 32.6 Hz C-4), 127.1 (C-2’,6’), 125.3 
(q, J = 3.8 Hz C-3’, 5’), 124.3 (q, J = 273.4 Hz, -CF3), 107.0 (C-3), 106.0 (C-5), 82.0 (-
C(CH3)3), 46.9 (C-2’’, 5’’, 28.1 (-(CH3)3), 25.5 (C-3’’, 4’’).  δF (376 MHz, CDCl3) -62.49 (-CF3). 
νmax (ATR) 2972, 2839, 2259, 1734, 1604, 1566, 1443, 1326, 1251, 1124 cm-1. GC/MS (EI) 
m/z found 393.5 ([M+H]+ 100%), Accurate Mass (ES+) m/z found [M+H]+  393.1785, 
C21H24F3N2O2 requires M 393.1789.   
 
13 2-(4’-nitrophenyl)-6-(pyrrolidin-1”-yl)-4-(pyrrolidine-1’’’-carbonyl)pyridine  
Following procedure D and purification using EtOAc in hexane (0-50%) yielded the 
title compound as a yellow solid (275 mg, 75 %). mp  239.5-240.5 oC. δH (500 MHz, 
CDCl3) 8.29-8.21 (2H, m, 3’,5’-H), 8.21-8.14 (2H, m, 2’,6’-H), 7.1 (1H, s, 3-H), 6.4 
(1H, s, 5-H), 3.7 (2H, t, J = 7.0 Hz, 2”’-H2), 3.60-3.49 (4H, m, 2”,5”-H2), 3.43 (2H, t, J 
= 6.7 Hz, 5”’-H2), 2.06-2.01 (4H, m, 3”,4”-H2), 2.0 (2H, p, J = 7.0 Hz, 3”’-H2), 1.9 (2H, 
p, J = 6.7 Hz, 4”’-H2); δC (125 MHz, CDCl3) 168.4 (C=O), 157.2 (C-6), 153.3 (C-2), 
148.0 (C-4’), 146.9 (C-4), 145.8 (C-1’), 127.5 (C-2’,6’), 123.8 (C-3’,5’), 106.0 (C-3), 
104.1 (C-5), 49.4 (C-5“’), 46.9 (C-2”,5”), 46.2 (C-2”’), 26.4 (C-4”’), 25.6 (C-3”,4”), 
24.5 (C-3”’); νmax 1618, 1616, 1598, 1541, 1512, 1478, 1456, 1442, 1419, 1344, 1322, 
1102, 858, 755, 702, 513 cm-1; m/z (LC-MS, ES+) 1121 ([M3Na]+, 38%), 755 ([M2Na]+, 
81%), 366 ([M]+, 100%); Accurate mass (ES+) m/z found [MH]+ 367.1781; C20H23N4O3 
requires M, 367.1770.  
 
(17w) Methyl 6-chloro-5-(3-methoxyphenyl)pyridine-3-carboxylate 
Following general procedure and purification using EtOAc in heptane (0-15%) yielded the 
title compound as a white amorphous solid (229 mg, 76%). δH (700 MHz, CDCl3) 8.49 (1H, 
d, J = 2.2, 6-H), 8.34 (1H, d, J = 2.2, 4-H), 7.48 (2H, m, 2’, 6’-H), 7.00 (2H, m, 3’, 5’-H), 
4.10 (3H, s, 2-COCH3), 3.93 (3H, s, CO2CH3), 3.86 (3H, s, 4’-OCH3); δC (176 MHz, CDCl3) 
165.7 (CO2CH3), 161.4 (C-2), 159.7 (C-4’), 148.2 (C-6), 139.7 (C-4), 129.8 (C-5), 129.3 (C-
1’), 128.0 (C-2’, 6’), 114.7 (C-3’, 5’), 113.9 (C-3), 55.5 (4’-OCH3), 54.6 (2-COCH3), 52.5 
(CO2CH3); νmax (ATR) 1732, 1606, 1563, 1519, 1474, 1417, 1327, 1285, 1245, 1181, 1087, 
1060, 1014 cm−1; Accurate Mass (ASAP) m/z found [M+H]+ 274.1075; C15H16NO4 requires 
M, 274.1079.  
 
(17’y) Methyl 6-fluoro-5-(4’-methoxyphenyl)pyridine-3-carboxylate 
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Following general procedure A and purification using  EtOAc in hexane (0-50%) yielded the 
title product as a pale yellow amorphous solid (107 mg, 58%). δH (600 MHz, CDCl3) 8.77 
(1H, m, 6-H), 8.45 (1H, m, 4-H), 7.54 (2H, d, J = 8.6, 2’, 5’-H), 7.01 (2H, d, J = 8.6, 3’, 5’-
H), 3.96 (3H, s, CO2CH3), 3.86 (3H, s, OCH3); δC (151 MHz, CDCl3) 165.0 (CO2CH3), 162.6 
(d, J = 246.2, C-6), 160.3 (C-4’), 147.8 (dd, J = 16.7, 5.1, C-6), 141.5 (d, J = 6.4, C-4), 130.2 
(d, J = 6.4, C-2’, 6’), 125.1 (m, C-1’), 123.7 (d, J = 28.6, C-3), 114.5 (C-3’, 5’), 55.5 (OCH3), 
52.7 (CO2CH3); δF (376 MHz, CDCl3) −65.4 (s); νmax (ATR) 1725, 1609, 1518, 1434, 1411, 
1313, 1250, 1200, 1181, 1120, 1047, 1029 cm−1; Accurate Mass (ASAP) m/z found [M]+ 
261.0819; C14H12FNO3 requires M, 261.0801.  
 
(20yB) Methyl 5-(4’-methoxyphenyl)-6-(morpholin-4”-yl)pyridine-3-carboxylate 
Following general procedure B and purification using EtOAc in hexane (0-20%) yielded the 
title compound as a light yellow solid (22 mg, 88%). mp 242-243 oC. δH (599 MHz, CDCl3) 
8.78 (1H, d, J = 2.3 Hz, 6-H), 7.97 (1H, d, J = 2.3 Hz, 4-H), 7.44 (2H, d, J = 8.3 Hz, 3’, 5’-
H), 6.95 (2H, d, J = 8.3 Hz, 3’, 6’-H), 3.88 (3H, s, CO2CH3), 3.84 (3H. s, 4’-OCH3), 3.62 
(4H, t, J = 4.5 Hz, 3’’, 5’’-H2), 3.24 (4H, t, J = 4.5 Hz, 2’’, 6’’-H2). δC (151 MHz, CDCl3) 
159.2 (C=O), 147.9 (C-4’), 140.7 (C-2), 131.4 (C-3), 128.7 (C-4), 127.8 (C-2’, 6’), 125.8 (C-
1’) , 124.8 (C-6), 118.5 (C-4), 114.4 (C-3’, 5’), 66.6 (-OCH3), 55.3 (CO2CH3), 51.9 (C-2’’, 
6’’), 48.7 (C-3’’, 5’’). νmax (ATR) 2967, 2854, 1717, 1596, 1509, 1411, 1361, 1249, 1234, 
1100 cm−1. m/z (LC-MS, ES+) 329.1 ([M+H]+, 100%), Accurate mass (ES+) m/z found 
[M+H]+ 329.1511; C18H21N2O4 requires M, 329.1501. 
 
(17y) Methyl 6-chloro-5-(4’-methoxyphenyl)pyridine-3-carboxylate 
Following general procedure A and purification using CHCl3 in hexane (0-50%) yielded the 
title compound as an off white solid (169 mg, 61%). mp 171-172 oC. δH (700 MHz, CDCl3) 
8.93 (1H, d, J = 2.3 Hz, 6-H), 8.24 (1H, d, J = 2.3 Hz, 4-H), 7.42 (2H, d, J = 8.7 Hz, 2’, 6’-
H), 6.99 (2H, d, J = 8.7 Hz, 3’, 5’-H), 3.95 (3H, s, CO2CH3), 3.86 (3H, s, -OCH3). δC (176 
MHz, CDCl3) 165.0 (C=O), 159.9 (C-4’), 153.8 (C-2), 148.9 (C-6), 140.2 (C-4), 136.5 (C-3), 
130.5 (C-2’, 6’), 128.7 (C-1’), 125.2 (C-5), 113.9 (C-3’, 5’), 55.3 (4’-OCH3), 52.6 (CO2CH3). 
νmax (ATR) 2960, 2849, 1726, 1614, 1591, 1523, 1446, 1394, 1317, 1252, 1181 cm−1.  m/z 
(LC-MS, ES+) 279.0 ([M(35Cl)+H]+, 100%), 281.1 ([M(37Cl)+H]+, 28%), Accurate mass 
(ES+) m/z found [M(35Cl)+H]+ 278.0601, C14H13NO335Cl requires M 278.0584. 
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(20yA) Methyl 5-(4’-methoxyphenyl)-6-(pyrrolidin-1”-yl)pyridine-3-carboxylate 
Following general procedure B and purification using EtOAC in hexane (0-15%) yielded the 
title compound as a light yellow amorphous solid (24 mg, 71%). δH (599 MHz, CDCl3) 8.03 
(2H, J = 8.8 Hz, 3’, 5’-H), 7.46 (1H, d, J = 1.2 Hz, 6-H), 6.97 (2H, d, J = 8.8 Hz, 2’, 6’-H), 
6.86 (1H, , d, J = 1.2 Hz, 4-H), 3.95 (3H, s, CO2CH3), 3.85 (2H, s, 4’-OCH3), 3.62 (2H, m, 
2’’, 5’’-H2), 2.08 – 2.01 (1H, m, 3’’, 4’’-H2). δC (151 MHz, CDCl3) 166.7 (C=O), 160.5 (C-
4’), 157.0 (C-2), 155.6 (C-3), 139.1 (C-4), 128.3 (C-2’, 6’), 113.8 (C-3’, 5’), 113.1 (C-1’), 
105.9 (C-6), 104.4 (C-4), 55.3 (-OCH3), 52.4 (CO2CH3), 47.0 (C-2’’, 5’’), 25.5 (C-3’’, 4’’). 
νmax (ATR) 2972, 1731, 1607, 1557, 1518, 1477, 1459, 1246, 1216, 1178, 1030 cm−1.  m/z 
(LC-MS, ES+) 313.1 ([M+H]+, 100%),  Accurate mass (ES+) m/z found [M+H]+ 313.1571, 
C18H21N2O3 requires M 313.1552.  
 
(17x) Methyl 6-chloro-5-[4’-(trifluoromethyl)phenyl]pyridine-3-carboxylate 
Following General procedure A and purification using C18 reverse phase chromatography 
(H2O: MeCN, 0-100%) yielded the title compound as an off white amorphous solid (173 mg, 
55%). δH (599 MHz, CDCl3)  9.02 (1H, d, J = 2.3 Hz, 6-H), 8.27 (1H, d, J = 2.3 Hz, 4-H), 
7.85 – 7.67 (2H, m, 3’, 5’-H ), 7.65 – 7.53 (2H, m, 2’, 6’-H), 3.98 (3H, s, CO2CH3). δC (151 
MHz, CDCl3) 164.6 (C=O), 153.5 (C-2), 150.0 (C-6), 140.2 (C-4), 140.0 (C-1’), 135.5 (C-2), 
131.01 (q, J = 32.8 Hz, C-4’) 129.7 (C-2’, 6’), 127.7 (C-4), 125.5 (q J = 3.7 Hz C-3’,5’), 
123.8 (q, J = 269.4 Hz, -CF3) 52.7 (CO2CH3). δF (376 MHz, CDCl3) -62.73 (-CF3). νmax 
(ATR) 3070, 2964, 1714, 1596, 1397, 1323, 1261, 1169, 1124, 1071 cm−1.  m/z (LC-MS, 
ES+) 316.4 ([M(35Cl)+H]+, 72%), 318.3 ([M(37Cl)+H]+, 22%), Accurate mass (ES+) m/z 
found [M(35Cl)+H]+ 316.0359, C14H1035ClF3NO2 requires M 316.0352. 
 
(20xA) Methyl 6-(pyrrolidin-1”-yl)-5-[4’-(trifluoromethyl)phenyl]pyridine-3-carboxylate 
Following general procedure C and purification using EtOAc in hexane (0-15%) yielded the 
title compound as a light yellow amorphous solid (36 mg, 88%). δH (599 MHz, CDCl3) 8.16 
(2H, d, J = 8.1 Hz, 3’, 5’-H), 7.68 (2H, d, J = 8.1 Hz, 2’, 6’-H), 7.53 (1H, d, J = 1.2 Hz, 6-H), 
6.95 (1H, d, J = 1.2 Hz, 4-H), 3.95 (3H, s, CO2CH3), 3.59 (4H, d, J = 6.4 Hz, C-2’’, 5’’-H2), 
2.09 – 1.97 (4H, m, C-3’’, 4’’-H2). δC (151 MHz, CDCl3) 166.44 (C=O), 157.3 (C-2), 154.50 
(C-5), 142.6 (C-3), 139.2 (C-1’), 130.7 (q, J = 32.6 Hz C-6’), 127.1 (C-3’, 5’), 125.35 (C-2’, 
6’), 124.1 (q, J = 263.78 Hz, CF3), 106.9 (C-6), 106.1 (C-4), 52.5 (-OCH3), 47.0 (C-2’’, 5’’), 
25.5 (C-3’’, 4’’). δF (376 MHz, CDCl3) δ -62.52. νmax (ATR) 2966, 2863, 1723, 1609, 1560, 
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1477, 1446, 1323, 1238, 1112 cm−1.  m/z (LC-MS, ES+) 351.1 ([M+H]+, 100%),  Accurate 
mass (ES+) m/z found [M+H]+ 351.1308, C18H18F3N2O2 requires M 351.1320.  
 
(18y) Tert butyl 6-chloro-5-(4’-methoxyphenyl)pyridine-3-carboxylate 
Following General procedure A and purification using EtOAc in hexane yielded the title 
compound as an off white solid (140 mg 44%). mp. 177-178 oC (methanol). δH (599 MHz, 
CDCl3) 8.86 (1H, d, J = 2.5 Hz, 6-H), 8.16 (1H, d, J = 2.4 Hz, 4-H), 7.39 (2H, d, J = 9.1, 2’, 
6’-H), 6.99 (2H, d, J = 9.1 Hz, 3’, 5’-H), 3.86 (3H, s, 4’-OCH3), 1.59 (9H, s, (CH3)3). δC (151 
MHz, CDCl3) 163.6 (C=O), 159.9 (C-4’), 153.3 (C-2), 148.9 (C-6), 140.1 (C-4), 136.3 (C-3), 
130.5 (C-2’, 6’), 129.0 (C-1’), 126.9 (C-5), 113.9 (C-3’ 5’), 82.5 (-C(CH3)3), 55.3 (-OCH3), 
28.1 (C(CH3)3). νmax (ATR) 2987, 2830, 2164, 1726, 1593, 1400, 1258, 1136, 1033 cm−1.  m/z 
(LC-MS, ES+) 320.1 ([M(35Cl)+H]+, 46%), 322.1 ([M(37Cl)+H]+, 18%), 264.0 ([M(35Cl)-
tBu+H]+, 100%), 266.0 ([M(37Cl)-tBu+H]+, 38%)   Accurate mass (ES+) m/z found 
[M(35Cl)+H]+ 320.1075, C17H1935ClNO3 requires M 320.1053. 
 
(21yA) Tert butyl 5-(4’-methoxyphenyl)-6-(pyrrolidin-1”-yl)pyridine-3-carboxylate 
Following general procedure D and purification using EtOAC in hexane (0-20%) yielded the 
title compound as a light yellow solid (26 mg, 75%). mp 248-249 oC (ethanol). δH (700 MHz, 
CDCl3) 8.73 (1H, d, J = 2.2 Hz, 6-H), 7.83 (d, J = 2.2 Hz, 1H), 7.24 – 7.20 (2H, m, 2’, 6’-H), 
6.91 – 6.87 (2H, m, 3’, 5’-H), 3.83 (3H, s, 4’-OCH3), 3.17 – 3.23 (4H, m, 2’’, 5’’-H2), 1.79 – 
1.75 (4H, m, 3’’, 4’’-H2), 1.54 (9H, s, C(CH3)3). δC (176 MHz, CDCl3) 165.3 (C=O), 158.6 
(C-4’), 148.2 (C-6), 140.6 (C-4), 132.4 (C-1’) 130.1 (C-2’, 6’), 128.3 (C-2), 127.8 (C-3), 
116.7 (C-5) 113.4 (C-3’, 5’), 80.5 (C(CH3)3), 55.7 (-OCH3), 50.3 (C-2’’, 5’’), 28.3 (C(CH3)3), 
25.6 (C-3’’, 4’’). νmax (ATR) 2985, 2880, 2256, 1699, 1598, 1513, 1459, 1308, 1251, 1166 
cm−1. m/z (LC-MS, ES+) 355.2 ([M+H]+, 100%), Accurate mass (ES+) m/z found [M+H]+ 
355.2033, C21H27N2O3 requires M 355.2022 
 
(21yB) Tert butyl 5-(4’-methoxyphenyl)-6-(morpholin-4”-yl)pyridine-3-carboxylate 
Following general procedure D and purification using EtOAC in hexane (0-20%) yielded the 
title compound as a light yellow amorphous solid (30 mg, 87%). δH (700 MHz, CDCl3) 8.74 
(1H, d, J = 2.3 Hz, 6-H), 7.92 (1H, d, J = 2.3 Hz, 4-H), 7.45 (2H, d, J = 8.7 Hz, 2’, 6’-C), 
6.95 (2H, d, J = 8.7 Hz, 3’, 5--H), 3.84 (3H, s, 4’-OCH3), 3.61 (4H, t, J = 4.7 Hz, 3’’, 5’’-H2), 
3.21 (4H, t, J = 4.7 Hz, 2’’, 6’’-H2), 1.56 (9H, s, C(CH3)3). δC (176 MHz, CDCl3)  164.9 
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(C=O), 159.1 (C-4’), 147.7 (C-5), 140.5 (C-4), 131.6 (C-1’), 128.8 (C-2’’, 6’’),  125.7 (C-2), 
124.7 (C-3), 120.4 (C-5), 114.3 (C-3’’, 5’’), 81.1 (C(CH3)3), 66.6 (C-2’’, 6’’), 55.3 (-OCH3), 
48.8 (C-3’’, 5’’), 28.3 (C(CH3)3). νmax (ATR) 2967, 2246, 1731, 1569, 1414, 1320, 1112 
cm−1.  m/z (LC-MS, ES+) 371.2 ([M+H]+, 100%), Accurate mass (ES+) m/z found [M+H]+ 
371.2000, C21H26N2O4 requires M 371.1971. 
 
(18x) Tert butyl 6-chloro-5-[4’-(trifluoromethyl)phenyl]pyridine-3-carboxylate 
Following General procedure A and purification using C18 reverse phase chromatography 
(H2O: MeCN, 0-100%) yielded the title compound as a white solid (177 mg, 32%). mp 105-
106 oC. δH (700 MHz, CDCl3) 8.95 (1H, d, J = 2.3 Hz, 6-H), 8.18 (1H, d, J = 2.3 Hz, 3-H), 
7.78 – 7.71 (2H, m, 2’,6’-H), 7.61 – 7.56 (2H, m, 3’-5’-H), 1.61 (9H, s, C(CH3)3). δC (176 
MHz, CDCl3) 163.2 (C=O), 152.9 (C-2), 150.0 (C-6), 140.24 (C-1’), 140.1 (C-4), 135.2 (C-
3), 130.8 (q, J = 32.7 Hz, C-4‘) 129.7 (C-2’’, 6’’), 127.1 (C-5), 125.4 (q, J = 3.7 Hz, C-3’’, 
5’’) 123.8 (q, J = 272.6 Hz, -CF3) 82.9 (C(CH3)3), 28.1 (C(CH3)3). δF (376 MHz, CDCl3) -
62.70 (-CF3). νmax (ATR) 2983, 2930, 1723, 1623,1598, 1392, 1320, 1261, 1112 cm−1. m/z 
(LC-MS, ES+) 358.1 ([M(35Cl)+H]+, 42%), 360.1 ([M(37Cl)+H]+, 15%), 302.0 ([M(35Cl)-
tBu+H]+, 100%), 304.0 ([M(37Cl)-tBu+H]+, 38%)   Accurate mass (ES+) m/z found 
[M(35Cl)+H]+ 358.0828, C17H1635ClNO2F3 requires M 358.0822. 
  
(21xB) Tert butyl 6-(morpholin-4”-yl)-5-[4’-(trifluoromethyl)phenyl]pyridine-3-carboxylate 
Following general procedure D and purification using EtOAC in hexane (0-20%) yielded the 
title compound as an off white amorphous solid (41 mg, 82%) δH (599 MHz, CDCl3) 8.80 
(1H, d, J = 2.2 Hz, 6-H), 7.95 (1H, d, J = 2.2 Hz, 4-H), 7.67 (4H, m, Ar-H), 3.60 (4H, t, J = 
4.7 Hz, 3’’, 5’’-H2), 3.20 (4H, t, J = 4.7 Hz, 2’’, 6’’-H2), 1.56 (9H, s, C(CH3)3). δC (151 MHz, 
CDCl3) 164.6 (C=O), 160.8 (C-2), 149.1 (C-6), 143.26 (C-1’), 140.8 (C-4), 129.9 (q, J = 33.1 
Hz C-4’)), 127.9 (C-2’, 6’), 125.9 (q, J = 3.7 Hz, C-3’, 5’), 123.9 (q, J = 278.0 Hz, -CF3) 
120.47 (C-5), 81.3 (-C(CH3)3, 66.4 (C-3’’, 5’’), 49.1 (C-2’’, 6’’), 28.2 (C(CH3)3). δF (376 
MHz, CDCl3) -62.55 (-CF3). νmax (ATR) 2950, 2829, 1729, 1678, 1610, 1497, 1343, 1265, 
1184 cm−1. m/z (LC-MS, ES+) 409.1 ([M+H]+, 100%), 353.1 ([M-tBu+H]+, 52%), Accurate 
mass (ES+) m/z found [M+H]+ 409.1750, C21H24F3N2O3 requires M 409.1739. 
 
(22zA) Methyl 5-(4’-nitrophenyl)-2-(pyrrolidin-1”-yl)pyridine-3-carboxylate 
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Following general procedure A gave the crude aryl-nicotinate intermediate which was used 
without further purification according to general procedure C to yield, upon purification 
using EtOAc in hexane (0-25%) the title compound as a dark yellow amorphous solid (62 
mg, 32%), δH (700 MHz, CDCl3) 8.58 (1H, d, J = 2.5 Hz, 6-H), 8.27 (2H, d, J = 8.8 Hz, 3’, 
5’-H), 8.17 (1H, d, J = 2.5 Hz, 3-H), 7.67 (2H, d, J = 8.8 Hz, 2’, 6’-H), 3.93 (3H, s, 
CO2CH3), 3.51 (4H, d, J = 6.6 Hz, 2’’, 5’’-H2), 1.99 (4H, d, J = 6.6 Hz, 3’’, 4’’-H2). δC (176 
MHz, CDCl3) 167.2 (C=O), 155.42 (C-2), 152.92 (C-3), 146.6 (C-4’), 130.41 (C-6), 129.00, 
126.2, (C-2’’, C-6’’), 124.4 (C-3’, 5’), 121.5 (C-5), 117.48 (C-1’), 52.49 (CO2CH3), 50.30 
(C-2’’, 5’’), 25.58 (C-3’’, 4’’). νmax (ATR) 2925, 2291, 1970, 1757, 1669, 1561, 1533, 1371, 
1280, 1168 cm−1. m/z (LC-MS, ES+) 328.1 ([M+H]+, 100%), Accurate mass (ES+) m/z found 
[M+H]+ 328.1291, C17H18N3O4 requires M 328.1297. 
 
(19y) Methyl 2-chloro-5-(4’-methoxyphenyl)pyridine-3-carboxylate 
Following general procedure A and purification using EtOAc in hexane (0-25%) yielded the 
title compound as a white amorphous solid. Purification using (0-35% EtOAc-hexane,) 
afforded the title compounds as an amorphous white solid (55 mg, 20%) δH (700 MHz, 
CDCl3) 8.71-8.64 (1H, m, 6-H), 8.30 (1H, d, J = 2.5, 4-H), 7.54-7.50 (2H, m, 2-H), 7.04-6.98 
(2H, m, 3',5’-H), 3.98 (3H, s, CO2CH3), 3.86 (3H, s, 4'-OCH3); δC (176 MHz, CDCl3) 165.1 
(C=O), 160.3 (C-2), 149.5 (C-6), 147.8 (C-5), 137.9 (C-4), 135.2 (C-1), 128.2 (C-2'), 127.7 
(C-1’), 126.4 (C-3), 114.8 (C-3'), 55.4 (5'-OCH3), 52.9 (CO2CH3); νmax (ATR) 3019, 2961, 
2933, 2839, 1737 (s) (C=O), 1608, 1582, 1552, 1515, 1324, 1310, 1293, 1226, 1184, 1064, 
1054, 1033, cm−1. m/z (LC-MS, ES+) [M+H]+ 279.8 (100), Accurate mass (ES+) m/z found 
[M+H]+ 278.0583, C14H13NO3Cl requires M 278.0584. 
(22yB) Methyl 5-(4”-methoxyphenyl)-2-(morpholin-4’-yl)pyridine-3-carboxylate 
Following general method C and purification using EtOAc in heptane (20-30%) yielded the 
title product as a white amorphous solid (141 mg, 93%). δH (700 MHz, CDCl3) 8.51 (1H, s, 
6-H), 8.20 (1H, s, 4-H), 7.47 (2H, d, J = 8.0, 2’’,6’’-H), 6.98 (2H, d, J = 8.0, 3’’, 5’’-H), 3.91 
(3H, s, CO2CH3), 3.85 (7H, m, OCH3, 3’, 5’-H2), 3.44 (4H, m, 2’, 6’-H2); δC (176 MHz, 
CDCl3) 167.5 (CO2CH3), 159.3 (C-4’’), 158.2 (C-2), 148.4 (C-6), 138.8 (C-4), 129.5 (C-1’’), 
127.6 (C-5), 127.4 (C-2’’, 6’’), 114.5 (C-3’’, 5’’), 113.6 (C-3), 66.9 (C-3’, 5’), 55.4 (OCH3), 
52.2 (CO2CH3), 49.9 (C-2’’, 6’’); νmax (ATR) 1717, 1601, 1472, 1440, 1246, 1212, 1182, 
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1114, 1087 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 329.1510; C18H21N2O4 requires M, 
329.1501. 
 
(22yC) Methyl 5-(4”-methoxyphenyl)-2-(piperidin-1’-yl)pyridine-3-carboxylate 
Following general procedure C and purification using EtOAc in heptane yielded the title 
compound as a yellow amorphous solid (57 mg, 89%). δH (700 MHz, CDCl3) 8.47 (1H, d, J = 
2.4, 6-H), 8.11 (1H, d, J = 2.4, 4-H), 7.45 (2H, d, J = 8.6, 2’’, 6’’-H), 6.97 (2H, d, J = 8.6, 3’’, 
5’’-H), 3.91 (3H, s, CO2CH3), 3.84 (3H, s, OCH3), 3.39 (4H, m, 2’, 6’-H2), 1.68 (6H, m, 3’, 
4’, 5’-H2); δC (176 MHz, CDCl3) 168.4 (CO2CH3), 159.2 (C-4’’), 158.6 (C-2), 148.3 (C-6), 
138.7 (C-4), 130.0 (C-1’’), 127.5 (C-2’’, 6’’), 126.4 (C-5) 114.6 (C-3’’, 5’’), 113.4 (C-3), 
55.5 (OCH3), 52.3 (CO2CH3), 50.7 (C-2’, 6’), 26.1 (AlkC), 24.7 (AlkC); υmax (ATR) 1716, 
1694, 1608, 1441, 1247, 1180 cm−1; Accurate Mass (ESI) m/z found [M+H]+ 327.1701; 
C19H23N2O3 requires M, 327.1709. 
 
(22yE) Methyl 2-(butylamino)-5-(4’-methoxyphenyl)pyridine-3-carboxylate 
Following general procedure C and purification using EtOAC in hexane (0-20%) 
yielded the title compound as a yellow amorphous solid (38 mg, 60%). δH (700 MHz, 
CDCl3) 8.50 (1H, d, J = 2.5 Hz, 6-H), 8.32 (1H, d, J = 2.5 Hz, 4-H), 7.42 (2H, d, J = 8.7 
Hz, 2’, 6’-H), 6.96 (2H, d, J = 8.7 Hz, 3’, 5’-H), 3.89 (3H, s, CO2CH3), 3.83 (3H, s, 4’-
OCH3), 3.60-3.52 (2H, m, 1’’-H2), 1.71 – 1.63 (2H, m, 2’’-H2), 1.52 – 1.42 (2H, m, 3’’-
H2), 0.97 (3H, t, J = 7.4 Hz, 4’’-H3). δC NMR (176 MHz, CDCl3) 162.6 (C=O), 159.0 
(C-4’), 152.9 (C-2), 146.4 (C-6), 138.6 (C-4), 131.0 (C-1’), 127.1 (C-2’, 6’), 123.9 (C-
5), 117.8 (C-4), 114.4 (C-3’, 5’), 67.1 (C-1’’), 55.4 (-OCH3), 52.0 (CO2CH3), 31.6 (C-
2’’), 20.3 (C-3’’), 13.9 (C-4’’). υmax (ATR) 3381, 2960, 2259, 1693, 1611, 1504, 1243, 
1036 cm−1.  m/z (LC-MS, ES+) 313.3 ([M-H]-, 100%), Accurate mass (ES+) m/z found 
[M+H]+ 315.1705, C18H23N2O3 requires M 315.1709.  
(19’y) Methyl 2-fluoro-5-(4-methoxyphenyl)pyridine-3-carboxylate 
Following general procedure A, and purification using EtOAc in heptane (0-20% ) yielded 
the title product as an off-white amorphous solid (715 mg, 62%). δH (700 MHz, CDCl3) 8.51 
(2H, m, 4, 6-H), 7.50 (2H, m, 2’, 6’-H), 7.01 (2H, m, 3’, 5’-H), 3.98 (3H, s, CO2CH3), 3.86 
(OCH3); δC (176 MHz, CDCl3) 164.0 (d, J = 8.1, CO2CH3), 160.5 (d, J = 249.8, C-2), 160.3 
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(C-4’), 149.1 (d, J = 15.4, ArC), 141.7 (d, J = 1.6, ArC), 135.0 (C-5), 128.3 (C-2’, 6’), 128.0 
(C-1’), 114.9 (C-3, 5’), 113.4 (d, J = 25.6, C-3), 55.6 (OCH3), 53.0 (CO2CH3); δF (376 MHz, 
CDCl3) −66.3 (s); νmax (ATR) 1722, 1603, 1459, 1446, 1327, 1292, 1249, 1179, 1089, 1042, 
977 cm−1; Accurate Mass (ASAP) m/z found [M]+ 261.0824; C14H12FNO3 requires M, 
261.0801 
 
(19’’y) Methyl 2-methoxy-5-(4-methoxyphenyl)pyridine-3-carboxylate 
Following general procedure A and purification using EtOAc in heptane (0-15%) 
yielded the title compound as a white amorphous solid (229 mg, 76%). δH (700 MHz, 
CDCl3) 8.49 (1H, d, J = 2.2, 6-H), 8.34 (1H, d, J = 2.2, 4-H), 7.48 (2H, m, 2’, 6’-H), 
7.00 (2H, m, 3’, 5’-H), 4.10 (3H, s, 2-OCH3), 3.93 (3H, s, CO2CH3), 3.86 (3H, s, 4’-
OCH3); δC (176 MHz, CDCl3) 165.7 (CO2CH3), 161.4 (C-2), 159.7 (C-4’), 148.2 (C-6), 
139.7 (C-4), 129.8 (C-5), 129.3 (C-1’), 128.0 (C-2’, 6’), 114.7 (C-3’, 5’), 113.9 (C-3), 
55.5 (4’-COCH3), 54.6 (2-COCH3), 52.5 (CO2CH3); νmax (ATR) 1732, 1606, 1563, 
1519, 1474, 1417, 1327, 1285, 1245, 1181, 1087, 1060, 1014 cm−1. Accurate Mass 
(ASAP) m/z found [M+H]+ 274.1075; C15H16NO4 requires M, 274.1079. 
(19x) Methyl 2-chloro-5-[4’-(trifluoromethyl)phenyl]pyridine-3-carboxylate 
Following general procedure A and purification using EtOAc in hexane (0-15%) to yield the 
title compound as a white amorphous solid (64 mg, 24%); δH (700 MHz, CDCl3) 8.74 (1H, 
m, 6-H), 8.,37 (1H, d, J = 2.1, 4-H), 7.77 (2H, d, J = 8.1, C-2’, 6’), 7.70 (2H, d, J = 8.1, C-3’, 
5’), 4.00 (3H, s, CO2CH3). δC (176 MHz, CDCl3) δ 164.9 (C=O), 149.9 (C-2), 149.8 (C-6), 
139.1 (C-5), 138.9 (C-4), 134.2 (C-1’), 131.2 (q, J=33.2 Hz, C-4’), 127.7 (C-2’, 6’), 126.5 (q, 
J=3.8 Hz, C-3’, 5’)), 124.0 (q, J=272.0 Hz, -CF3), 121.5 (C-3), 53.2 (CO2CH3), δF (376 MHz, 
CDCl3) δ -62.83 (-CF3); νmax (ATR) 2174, 1982, 1730 (C=O), 1555, 1520, 1414, 1224, 1111, 
1052, 1033, 962, cm-1; m/z (LCMS-ESI) 318 ([M(37Cl)]+, 31 %), 316 ([M(35Cl)+H]+), 100), 
Accurate Mass (ESI-TOF) m/z Found [M+H]+ 316.0345, C14H20NO2F335CI requires M 
316.0352. 
 
(22xA) Methyl 2-(pyrrolidin-1”-yl)-5-[4’-trifluoromethylphenyl]pyridine-3-carboxylate 
 
Following general procedure C and purification using EtOAc in hexane (0-20%) yielded the 
title compound as an amorphous white solid (23 mg, 50%). δH (700 MHz, CDCl3) 8.53 (1H, 
bs, 6-H), 8.11 (1H, d, J = 2.2, 4-H), 7.69-7.61 (4H, m, Ar), 3.92 (3H, s, CO2CH3), 3.47-3.45 
(4H, m, 2", 5"-H2), 1.97-1.94 (4H, m, 3",4"-H2); δC (176 MHz, CDCl3) 167.7 (C=O), 155.3, 
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148.7, 141.1, 138.0 128.7, 126.6,  126.1, 124.4, 122.7, 110.8, 52.4, 49.9, 25.8; δF (564 MHz, 
CDCl3) -62.42; νmax (ATR) 2979, 2954, 2876, 1710 (C=O) , 1599, 1546, 1488, 1479, 1321, 
1244, 1211, 1160, 1137, 1116, 1100,cm-1; m/z (LCMS-ESI) 350 ([M]+, 86 %), 351 ([M+H]+, 
100%), Accurate Mass (ESI-TOF) m/z Found [M+H]+ 351.1300, C18H19N2O2F3 requires M 
351.1320. 
 
(22xB) Methyl 2-(morpholin-4"-yl)-5-[4’-(trifluoromethyl)phenyl]pyridine-3-carboxylate 
 
Following general procedure C and purification using EtOAc in DCM (0-20%) yielded the 
title compound as a white amorphous solid (16 mg, 43%) ; δH, (700 MHz, CDCl3) 8.56-8.54 
(1H, m, 6-H), 8.25 (1H, d, J 2.5 Hz, 4-H), 7.71-7.63 (4H, m, Ar), 3.93 (3H, s, CO2CH3), 3.85-
3.81 (4H, m, 3", 5"-H2), 3.52-3.49 (4H, m, 2", 6"-H2); δC (176 MHz, CDCl3) 167.3 (C=O), 
158.6 (C-2), 148.7 (C-6), 140.6 (C-1’), 139.5 (C-4) 129.4 (q, J = 32.4 Hz, C-4'), 126.4 (C-
2’,6’), 126.0 (q, J = 33.1 Hz, C-3’, 5’), 124.1 (q, J = 272.2 Hz, CF3), 123.1 (C-5) 113.1 (C-3), 
66.8 (C-3", 5"), 52.4 (CO2CH3), 49.6 (C-2", 6"); δF (376 MHz, CDCl3) -62.47 (CF3); νmax 
2957, 2925, 2847, 1707 (C=O), 1599, 1537, 1526, 1478, 1452, 1441, 1422, 1324, 1252, 
1213, 1162, 1109, 1098, 1073, 1052, 1043, 1016 cm-1, m/z (LCMS-ESI) 367 ([M+H]+, 
100%). Accurate Mass (ESI-TOF) m/z Found [M+H]+ 367.1265, C18H18N2O3F3 requires M 
367.1270 
 
(22xC) Methyl 2-(piperidin-1"-yl)-5-[4’-(trifluoromethyl)phenyl]pyridine-3-carboxylate 
 
Following general procedure C and purification using EtOAc in DCM (0-20%) yielded the 
title compound as a white amorphous solid; (5 mg, 13%); δH (700 MHz, CDCl3) 8.52 (1H, d, 
J = 2.5, 6-H), 8.17 (1H, d, J = 2.5, 4-H), 7.70-7.61 (4H, m, Ar), 3.91 (3H, s, CO2CH3), 3.45 
(4H, bs, 2", 6"-H2), 1.69 (6H, bs,  3",4" ,5"-H2); δC (176 MHz, CDCl3) 168.0, 157.3, 148.6, 
141.0, 139.3, 129.4, 126.4, 126.0, 125.2, 123.6, 112.9, 52.4, 50.4, 26.0, 24.7; δF (376 MHz, 
CDCl3) -62.42 (-CF3); νmax 2952, 2876, 2360, 1711 (C=O), 1599, 1541, 1489, 1480, 1461, 
1448, 1434, 1322, 1244, 1211, 1160, 1138, 1102, 1086, 1071, 1052, 1014 cm-1; m/z (LCMS-
ESI) 364 ([M]+, 60%), 365 ([M+H]+, 100%), Accurate Mass (ESI-TOF) m/z Found [M+H]+ 
365.1464, C19H21N2O2F3 requires M 365.1477. 
 
(19v) Methyl 2-chloro-5-(thiophen-3’-yl)pyridine-3-carboxylate 
 
Following general procedure A and purification using EtOAc in hexane (0-35%) yielded the 
title compound as an off white amorphous solid (55 mg, 19%). δH (400 MHz, CDCl3) 8.72 
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(1H, m, 6-H), 8.32 (1H, d, J = 2.4, 4-H), 7.58 (1H, dd, J = 3.0, 1.4, 4'-H), 7.47 (1H, dd, J = 
5.0, 3.0, 3'-H), 7.38 (1H, dd, J = 5.0, 1.4, 2'-H), 3.98 (3H, s, CO2CH3); δC (101 MHz, CDCl3) 
168.0 (C=O), 159.6, 157.3, 150.1, 143.2, 140.8, 136.5, 127.8, 125.7, 123.1, 53.0 (CO2CH3). 
νmax (ATR) 3091, 2960, 2360, 1738, 1722 (C=O), 1596 , 1562, 1525, 1432, 1418, 1404, 1327, 
1296, 1242, 1194, 1134, 1101, 1064, 918, 776 cm−1. m/z (GC-MS, ES+) 222 ([M-OMe]+), 
253 ([M]+); Accurate Mass (ESI-TOF) m/z Found [M+H]+ 254.0048, C11H9NO2S35CI 
requires M 254.0043. 
 
(19s) Methyl 2-chloro-5-phenylpyridine-3-carboxylate 
 
Following general procedure A and purification using EtOAc in hexane (0-35%) yielded the 
title compound as an off white amorphous solid (27 mg, 38%); δH, (700 MHz, CDCl3) 8.71 
(1H, d, J = 2.6, 6-H), 8.35 (d, J = 2.6, 1H, 4-H), 7.58 (2H, m, 2',6’-H), 7.50 (2H, m, 3',4’-H), 
7.45 (1H, t, J = 7.4, 4'-H), 3.99 (3H, s, CO2CH3); δc (176 MHz, CDCl3) 165.0 (3-CO2CH3, 
149.9 (C-6), 138.5 (C-4), 135.6, 135.4, 129.3, 129.3 (C- 3'), 128.9 (C-4), 127.0 (C-2'), 126.5, 
52.9 (3-CO2CH3); νmax (ATR) 2359, 2184, 1731 (C=O), 1425, 1317, 1255, 1129, 1064 cm−1. 
m/z (LCMS-ESI) 247 ([M]+, 67%), 248 ([M+H]+, 100).  
 
(19r) Methyl 2-chloro-5-[4’-(methoxycarbonyl)phenyl]pyridine-3-carboxylate 
 
Following general procedure A and purification using EtOAc in hexane (0-35%) yielded the 
title compound as a white amorphous solid (57 mg, 65 %); δH (700 MHz, CDCl3) 8.76 (1H, 
bs, 6-H), 8.39 (1H, d, J = 2.4, 4-H), 8.17 (2H, d, J = 8.3, Ar-H), 7.66 (2H, d, J = 8.3, Ar -H), 
4.00 (3H, s, 4’-CO2CH3), 3.96 (3H, s, 3-CO2CH3); δc (176 MHz, CDCl3) 166.4 (4’-CO2CH3), 
164.8 (3-CO2CH3) 149.9 (C-6), 149.5 (C-2), 139.7 (C-4), 138.7 (C-3), 130.5 (C-3’,5’), 130.5 
(C-4'), 127.0 (C-5), 123.3 (C-2’, 6’), 121.8 (C-1’), 53.0 (3-CO2CH3), 52.3 (4’-CO2CH3); νmax 
(ATR) 2364, 1711 (C=O), 1427 , 1275, 1108, 1060, 767, 421 cm−1. m/z (LCMS-ESI); 306 
([M+H]+ 100 %), 307 ([M+2]+, 32%), 328 ([M+Na]+, 9%); Accurate Mass (ESI-TOF) m/z 
Found [M+H]+ 306.0540, C15H13ClNO4 requires M 306.0533. 
 
(22rA) Methyl 5-[4’-(methoxycarbonyl)phenyl]-2-(pyrrolidin-1”’-yl)pyridine-3-carboxylate 
 
Following general procedure C and purification using EtOAC in hexane (0-20%) yielded the 
title compound as an off white amorphous solid (19 mg, 81%). δH (700 MHz, CDCl3) 8.56 
(1H, d, J = 2.5 Hz, 6-H), 8.15 (1H, d, J = 2.5 Hz, 4-H), 8.07 (1H d, J = 8.4 Hz, 2’, 6’-H), 7.59 
(2H, d, J = 8.4 Hz, 3’, 5’-H), 3.89-3.94 (6H, m, CO2Me), 3.48 (4H, t, J = 7.0, 2’’, 5’’-H2), 
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1.97 (4H, t,  J = 7.0, 3’’, 4’’-H2); δC (176 MHz, CDCl3) 168.9 (4’-C=O), 166.9 (3-C=O), 
144.1, 142.0, 138.3, 138.2, 134.0, 130.3, 128.4, 125.6, 122.8, 52.3, 52.1, 49.9, 25.6. νmax 
(ATR) 3025, 2957, 1719, 1591, 1536, 1477, 1462, 1438, 1326, 1273, 1089 cm−1. m/z 
(LCMS-ESI); 341.2 ([M+H]+ 100 %), Accurate mass (ES+) m/z found [M+H]+ 341.1509, 




Following general procedure C and purification with EtOAc in DCM (0-10%), yielded the 
title compound as a white amorphous solid (10 mg, 60 %); δH (700 MHz, CDCl3) 8.56 (1H, 
m, 6-H)), 8.29 (1H, d, J = 2.8, 8-H), 7.56 (2H, dd, J = 8.2, 1.4, 2’-H, 6’-H), 7.43 (2H, td, J = 
7.5, 8.2, 3', 5’-H), 7.33 (1H, td, J = 7.5, 1.4 Hz , m , 4'-H), 3.67-3.58 (4H, m, 2-H2, 3-H2), 
3.22 (3H, s, 4"-H), 3.13 (3H, s, 1"-H); δC (176 MHz, CDCl3) 169.3, 153.9, 149.5, 146.0, 
139.5, 130.6, 129.3, 127.8, 127.7, 127.6, 126.7, 118.8, 52.6, 48.4, 39.4, 36.0. vmax 2925, 
1716, 1632 (C=O) , 1599 , 1513, 1450, 1412, 1379, 1312, 1260, 1054, 1028  cm-1. m/z (LC-
MS, ES+) 268 ([M+H]+, 100), Accurate Mass (ESI-TOF) m/z found [M+H]+ 268.1456, 
C16H13N3O requires [M+H] 268.1450. 
 
(24) Methyl 2-(pyrrolidin-1’-yl)pyridine-3-carboxylate 
Following general procedure C and purification by 3 successive washes of the organic layer 
with water, the title compound was isolated as an orange oil (492 mg, 80%); δH (700 MHz, 
CDCl3) 8.21-8.17 (1H, m, 6-H), 7.80 (1H, m, 5-H), 6.53 (1H, m, 4H), 3.82 (3H, s, CO2CH3), 
3.35 (4H, t,  J  = 6.3, 2’,5’-H2), 1.87 (4H, m, 3’,4’-H2). δC (176 MHz, CDCl3) 167.9 (C=O), 
155.8 (C-2), 150.4 (C-6), 139.5 (C-5), 110.9 (C-4), 110.7 (C-3), 52.0 (OCH3), 49.5 (C-2’,5’), 
25.6 (C-3’, 4’); vmax 2948, 2872, 1709 (C=0), 1585, 1549, 1470, 1444, 1284, 1247, 1220, 
1114, 1083, 1053, 764, 746 cm-1; m/z (LCMS-ESI) 175 ([M-OMe]+, 75%), 206, ([M]+, 65%), 
208 ([M+2H]+, 100%), 209 ([M+3H]+, 20%) Accurate Mass (ESI-TOF) m/z found [M+H]+ 
207.1124, C11H15N2O2 requires M, 207.1134 
 
(25) Methyl 2-(4’-methoxyphenyl)pyridine-4-carboxylate 
Following general procedure A, the crude cross-coupling reaction product used without 
further purification and was dissolved in ethanol (20 mL) to which ammonium formate (2.5 
g, 40 mmol) was added. The reaction vessel was evacuated and backfilled with nitrogen (3 
cycles) before 10% Pd/C (106 mg, 0.1 mmol) was slowly added under a positive pressure of 
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nitrogen. The reaction was stirred at room temperature for 2 h then filtered through a plug of 
Celite and absorbed onto silica. Purification using EtOAc in hexane (0-20%) yielded the title 
compound as a white amorphous solid (230 mg, 47%). δH (700 MHz, CDCl3) 8.77 (1H, d, J = 
5.0 6-H), 8.22 (1H, s, 3-H), 8.01 (2H, m, 2’, 6’-H), 7.69 (1H, d, J = 5.0, 5-H), 7.00 (2H, m, 
3’, 5’-H), 3.97 (3H, s, CO2CH3), 3.86 (3H, s, OCH3); δc (176 MHz, CDCl3) 166.0 (CO2CH3), 
161.0 (C-4’), 158.2 (C-2), 150.4 (C-6), 138.1 (C-4), 131.2 (C-1’), 128.4 (C-2’, 6’), 120.4 (C-
5), 119.0 (C-3), 114.3 (C-3’, 5’), 55.5 (OCH3), 52.8 (CO2CH3); νmax (ATR) 1730, 1607, 1580, 
1557, 1516, 1467, 1436, 1421, 1390, 1301, 1274, 1249, 1176, 1111, 1060, 1031 cm−1; 
Accurate Mass (ASAP) m/z found [M+H]+ 244.0957; C14H14NO3 requires M, 244.0974. 
 
(26) methyl 2-(4’-nitrophenyl)-6-phenylpyridine-4-carboxylate 
Methyl 2-chloro-6-(4-nitrophenyl)pyridine-4-carboxylate (2cz) (130 mg, 0.45mmol, 1equiv.) 
was combined with phenyl boronic acid (1.2 equiv)) and CsCO3 (1.5 equiv) and was 
subjected to 3 N2 purge/refill cycles. DMAC (0.5M) was added and the vial was subjected to 
microwave irradiation for 18 hours at 100 oC. Purification using C18 reverse phase 
chromatography yielded the title compound as a yellow oil (36 mg, 24%). δH (700 MHz, 
CDCl3) 8.40 – 8.35 (4H, m), 8.33 (1H, d, J = 1.2 Hz), 8.31(1H, d, J = 1.2 Hz), 8.21 – 8.18 
(2H, m), 7.54 (2H dd, J = 8.2, 6.7 Hz), 7.49 (1H, d, J = 6.7 Hz,), 4.04 (3H, s, OCH3). δc (176 
MHz, CDCl3) 165.5, 158.5, 155.3, 148.4, 144.4, 139.6, 138.0, 129.9, 128.9, 127.9, 127.1, 
124.0, 119.3, 118.5, 53.0. νmax (ATR) 2970, 2801, 2299, 1731, 1662, 1572, 1496, 1331, 1271, 
1146 cm−1.  m/z (LCMS-ESI) 335.1 ([M+H]+, 100%), Accurate Mass (ES+) m/z found 
[M+H]+ 335.1046, C19H15N2O4 requires M, 335.1032. 
 
(27) Ethyl 2-{[2-(4’-methoxyphenyl)-6-(pyrrolidin-1”-yl)pyridin-4-yl]formamido}propanoate 
Tert butyl 2-(4-methoxyphenyl)-6-(pyrrolidin-1-yl)pyridine-4-carboxylate (3dyA) (38 mg, 
0.1mmol, 1equiv.) was treated with TFA for 1 hour when the reaction was concentrated in a 
stream of nitrogen. The crude residue was combined with HBTU (1.1equiv.), DMAP 
(1.1equiv.) and DCM (0.1M). The mixture was allowed to stir for 16 hours and quenched 
with water and extracted with DCM. Purification by column chromatography using EtOAc in 
Hexane (0-70%) afforded the title compound as a light yellow oil (31 mg, 67% (over 2 
steps)). δH (700 MHz, CDCl3) 8.01 (2H, d, J = 8.8 Hz, 2’, 6’-H), 7.16-7.20 (1H, m, 3-H), 
6.95 (2H, d, J = 8.8 Hz, 3’, 5’-H), 6.60-6.68 (1H, m, 5-H),  4.76 (1H, q, J = 7.2 Hz), 4.25 
(2H, q, J = 7.1 Hz, OCH2), 3.84 (3H, s, OCH3), 3.56-3.60 (4H, m, 2’’, 5’’-H), 1.99-2.03 (4H, 
m, 3’’, 4’’-H2), 1.54 (3H, d, J = 7.2 Hz, CαCH3), 1.31 (t, J = 7.1 Hz, CH2CH3). δC (176 MHz, 
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CDCl3) 173.0 (NHC=O), 166.5 (OC=O), 165.9 (C-4’), 160.5 (C-2), 143.4 (C-6), 131.0 (C-3), 
128.4 (C-2’, 6’), 128.3 (C-5), 127.8 (C-4), 125.8 (C-1’), 113.8 (C-3’, 5’), 61.7 (-OCH2), 55.3 
(OCH3), 48.6 (Cα) 48.2 (C-2’’, 5’’), 25.5 (C-3’’, 4’’), 18.2 (CαCH3), 14.1 (CH2CH3). νmax 
(ATR) 3227, 2975, 2259, 1738, 1655, 1604, 1518, 1456, 1349, 1026 cm−1. m/z (LCMS-ESI) 
398.7 ([M+H]+, 100%), Accurate Mass (ES+) m/z found [M+H]+ 398.2079, C22H28N3O4 
requires M, 398.2080  
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